Green Innovations (GNIN) 10-Q 14 Aug 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 12, 2014
Document And Entity Information	'	'
Entity Registrant Name	'GREEN INNOVATIONS LTD.	'
Entity Central Index Key	'0001491471	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	84,788,203
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
Current assets	'	'
Cash	$105,904	$38,305
Accounts receivable	167,323	91,227
Other receivable	2,000	'
Inventory, net	1,390,782	1,999,575
Prepaid expense	357,236	441,366
Total current assets	2,023,245	2,570,473
Intangible assets, net	808,744	838,411
Other assets	47,662	42,747
Total assets	2,879,651	3,451,631
Current liabilities	'	'
Convertible notes payable, net of discounts	3,033,202	1,781,272
Convertible notes payable, net of discounts, to related parties	350,000	320,000
Accounts payable	537,097	122,403
Accounts payable to related parties	65,227	31,953
Accrued expenses	108,523	61,054
Accrued expenses to related parties	71,212	'
Guaranteed value of stock	52,403	69,306
Total current liabilities	4,217,664	2,385,988
Long-term liabilities	'	'
Convertible notes, net of discounts	'	216,139
Total long-term liabilities	'	216,139
Commitments and contingencies (Note 5)	'	'
Amounts payable in common stock	511,669	1,079,348
Derivative liability	426,054	347,223
Total liabilities	5,155,387	4,028,698
Stockholders' deficit	'	'
Preferred stock, $0.0001 par value, 50,000,000 shares authorized Series A preferred stock, 5,000,000 shares authorized, 4,750,000 and 5,000,000 shares issued and outstanding, respectively	475	500
Preferred stock, $0.0001 par value, 50,000,000 shares authorized Series B preferred stock, 250,000 shares authorized, 250,000 and 0 shares issued and outstanding, respectively	25	'
Common stock, $0.0001 par value, 150,000,000 shares authorized, 123,503,428 and 85,252,830 shares issued, issuable and outstanding, respectively (45,315,225 and 27,149,158 shares issuable, respectively)	12,350	8,525
Additional paid-in capital	11,000,096	8,954,568
Accumulated deficit	-13,288,682	-9,540,660
Total stockholders' deficit	-2,275,736	-577,067
Total liabilities and stockholders' deficit	$2,879,651	$3,451,631

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Stockholders' deficit	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, Authorized	50,000,000	50,000,000
Preferred stock series A, Authorized	5,000,000	5,000,000
Preferred stock series A, Issued	4,750,000	5,000,000
Preferred stock series A, outstanding	4,750,000	5,000,000
Preferred stock series B, Authorized	250,000	250,000
Preferred stock series B, Issued	250,000	0
Preferred stock series B, outstanding	250,000	0
Common stock, par value	$0.00	$0.00
Common stock, Authorized	150,000,000	150,000,000
Common stock, Issued	123,503,428	45,315,225
Common stock, outstanding	85,252,830	27,149,158

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Consolidated Statements Of Operations	'	'	'	'
Revenue, net	$768,867	$437,940	$2,136,161	$599,645
Operating expenses	'	'	'	'
Direct costs of revenue	522,306	159,634	1,456,095	301,758
General and administrative (includes $275,777 and $573,446 for the three months ended June 30, 2014 and 2013, respectively, and $504,869 and $1,587,238 for the six months ended June 30, 2014 and 2013, respectively, of stock-based compensation and settlements)	1,057,739	879,563	2,223,269	2,036,821
Selling and marketing expenses	341,884	25,580	822,574	79,143
Operating loss	-1,153,062	-626,837	-2,365,777	-1,818,077
Other income (expense)	'	'	'	'
Beneficial conversion feature expense	-196,463	-165,535	-554,965	-165,535
Gain on sale of investment	107,455	'	321,455	'
Gain on cancellation of stock	'	'	1,707	'
Loss on conversion	'	'	-125,579	'
Loss on issuance of stock	-18,230	'	-40,602	'
Loss on sales of stock	'	'	-3,705	'
Loss on settlement of notes	'	'	-39,805	'
Change in derivatives	425,483	'	-678,652	'
Interest expense - amortization	'	'	-94,370	'
Interest expense	-90,300	-77,092	-167,729	-82,749
Total other income (expense)	227,945	-242,627	-1,382,245	-248,284
Net loss	($925,117)	($869,464)	($3,748,022)	($2,066,361)
Net loss per share - basic and diluted	($0.01)	($0.03)	($0.04)	($0.05)
Weighted average number of shares outstanding - Basic and Diluted	108,066,833	32,207,311	100,989,364	40,153,131

Consolidated_Statements_of_Ope1

Consolidated Statements of Operations (Parenthetical) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Consolidated Statements Of Operations	'	'	'	'
Selling, general and administrative	$275,777	$573,446	$504,869	$1,587,238

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:	'	'
Net loss	($3,748,022)	($2,066,361)
Adjustments to reconcile net loss to net cash used in operations:	'	'
Amortization of intangibles	29,667	19,667
Amortization of debt discounts to interest expense	94,370	'
Amortization of beneficial conversion features to interest expense	554,965	'
Amortization of options	'	126,980
Issuance of common stock for services	784,010	580,258
Issuance of warrants on contract	'	880,000
Debt accretion	'	165,535
Gain on sale of investment	-321,455	'
Change in derivatives	678,652	'
Loss on sales of stock	3,705	'
Loss on settlement of notes	39,805	'
Loss on issuance of stock	40,602	'
Loss on conversion	125,579	'
Gain on cancellation of stock	-1,707	'
Changes in operating assets and liabilities:	'	'
Accounts receivable	-76,096	-23,150
Other receivable	-2,000	'
Inventory, net	608,793	-1,195,345
Prepaid expense	84,130	'
Other assets	-4,915	'
Accounts payable	414,694	282,653
Accounts payable to related parties	33,274	-986
Accrued expenses	47,469	161,507
Accrued expenses to related parties	71,212	30,000
Guaranteed value of stock	16,903	'
Net cash used in operating activities	-526,366	-1,039,242
Cash flows from financing activities:	'	'
Proceeds from notes	555,000	546,060
Repayment of note	-343,557	-49,300
Proceed from line of credit	354,000	'
Proceeds from issuance of common stock	28,522	569,000
Net cash provided by financing activities	593,965	1,065,760
Net decrease in cash	67,599	26,518
Cash at beginning of period	38,305	45,743
Cash at end of period	105,904	72,261
Supplemental disclosure of cash flow information:	'	'
Cash paid for interest	129,394	'
Cash paid for taxes	'	'
Non-cash investing and financing activities:	'	'
Cancellation of common stock	'	-500
Issuance of preferred stock	'	500
Issuance of common stock for trademarks	'	600,000
Conversion of liabilities to notes payable	'	100,000
Issuance of common stock as condition of loan	$612,169	'

1_NATURE_OF_OPERATIONS_AND_SUM

1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 1 - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	Organization
	Green Innovations Ltd., formerly known as Winecom, Inc. (the “Company,” “we,” “us,” “our,” or “Green Innovations”) is a Nevada corporation. The business was started on July 1, 2008. We changed our name on September 24, 2012.
	Green Hygienics, Inc. (“Green Hygienics”), a Florida corporation, was formed on August 1, 2012. On September 26, 2012, it was acquired by the Company (see Note 2).
	Sensational Brands, Inc. (“Sensational Brands”), a Florida corporation, was formed on November 19, 2012. It was formed for the sole purpose of the acquisition of certain assets of Sensational Brands, Inc., a Texas corporation on November 19, 2012 (see Note 3). Sensational Brands was dissolved in September 2013 and its assets were assumed by Green Hygienics.
	Basis of Presentation
	The accompanying unaudited consolidated financial statements of Green Innovations Ltd. and Subsidiary have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. The results of operations for the interim period ended June 30, 2014 shown in this report are not necessarily indicative of results to be expected for the full fiscal year ending December 31, 2014. In the opinion of the Company’s management, the information contained herein reflects all adjustments (consisting of normal recurring adjustments and business combination adjustments – see Note 2) necessary for a fair presentation of the Company’s results of operations, financial position and cash flows. The unaudited interim financial statements should be read in conjunction with the audited consolidated financial statements in the Company’s Form 10-K for the year ended December 31, 2013 filed on March 18, 2014 and Management’s Discussion and Analysis of Financial Condition and Results of Operations.
	Nature of Operations
	The Company was formed to develop an Internet social website that catered to wine lovers. In August 2012, with the acquisition of Green Hygienics, the Company changed its operations to the business of importing and distributing bamboo-based hygienic products. The prior operations of the Company have been abandoned effective with the acquisition of Green Hygienics.
	Green Hygienics is in the importation, sale, and distribution of hygienic and household products made of bamboo-based paper. On August 1, 2012, Green Hygienics entered into a Licensing Agreement with American Hygienics Corporation (“AHC”), a corporation domiciled in the People's Republic of China, pursuant to we acquired the exclusive right for a period of 5 years to import and distribute AHC's proprietary bamboo pulp-based hygiene products. AHC is one of the world's largest manufacturer of bamboo-based wet wipes, is internationally certified (ISO 9001:2008, BRC-CP, EPA, Nordic swan, cGMP and GMP) and a member of the world Private Label Manufacturers Association. Exporting to over 45 countries, AHC supplies a number of Multi-National brands and retailers on all continents including customers such as 3M, Carrefour, Tesco, Walmart, and Goodyear. The Licensing Agreement contemplates the distribution of generic, private label, and Green Hygienics branded products, described below. Subject to certain sales targets being met, the exclusive distribution license will be renewable for an additional period of 5 years.
	Principles of Consolidation
	The consolidated financial statements include the accounts of Green Innovations and its wholly-owned subsidiary (as of June 30, 2014), Green Hygienics. All significant inter-company balances and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying consolidated financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
	Inventories
	Inventories are stated at the lower of cost or market (“LCM”). Inventory consists of finished goods.
	Impairment of Long-Lived Assets
	The Company accounts for long-lived assets in accordance with the provisions of Statement of Financial Accounting Standards ASC 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.
	Fair Value of Financial Instruments
	The Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For certain of our financial instruments, including cash, accounts payable, accrued expenses, deposits received from customers for layaway sales and short term loans the carrying amounts approximate fair value due to their short maturities.
	We follow accounting guidance for financial and non-financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
	Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
	Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.
	Revenue Recognition
	The Company recognizes revenue on our products in accordance with ASC 605-10, “Revenue Recognition in Financial Statements.” Under these guidelines, revenue is recognized on sales transactions when all of the following exist: persuasive evidence of an arrangement did exist, delivery of service has occurred, the sales price to the buyer is fixed or determinable and collectability is reasonably assured. The Company has one primary revenue stream as follows:
		·	Delivery of product to a merchant.
	The Company may have other revenue that deviates from the normal course of business. As of June 30, 2014, the Company has the following other revenue:
		·	Sale of investments – includes the sale of securities obtained for the compensation for the licensing rights to various products of the Company.
	Seasonal Revenue
	In the retail industry, there are typically seasonal periods of sales which cause fluctuations in revenue. The Company, due to the type of products it sells, does not have seasonal revenues.
	Stock-Based Compensation
	The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition provisions ASC Topic 505-50. The Company estimates the fair value of stock options at the grant date by using the Black-Scholes option-pricing model.
	Net Earnings (Loss) Per Share
	In accordance with ASC 260-10, “Earnings Per Share,” basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent shares which may dilute future earnings per share as of June 30, 2014 consist of convertible notes convertible into 44,208,745 common shares. Equivalent shares are not utilized when the effect is anti-dilutive (see Note 8).
	Segment Information
	In accordance with the provisions of ASC 280-10, “Disclosures about Segments of an Enterprise and Related Information,” the Company is required to report financial and descriptive information about its reportable operating segments. The Company does not have any operating segments as of June 30, 2014 and 2013.
	Effect of Recent Accounting Pronouncements
	The Company reviews new accounting pronouncements as issued. No new pronouncements had any material effect on these unaudited consolidated financial statements. The accounting pronouncements issued subsequent to the date of these unaudited consolidated financial statements that were considered significant by management were evaluated for the potential effect on these unaudited consolidated financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these unaudited consolidated financial statements as presented and does not anticipate the need for any future restatement of these unaudited consolidated financial statements because of the retro-active application of any accounting pronouncements issued subsequent to June 30, 2014 through the date these unaudited consolidated financial statements were issued.

2_BUSINESS_ACQUISITIONS_ASSET_

2. BUSINESS ACQUISITIONS, ASSET ACQUISITIONS, AND LICENSING AGREEMENTS	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 2 - BUSINESS ACQUISITIONS, ASSET ACQUISITIONS, AND LICENSING AGREEMENTS	'
	Green Hygienics, Inc.
	On September 26, 2012, the Company acquired all of the voting capital stock of Green Hygienics in exchange for 49,500,000 shares of common stock. Green Hygienics was owned solely by Bruce Harmon (“Harmon”). Green Hygienics had just begun its operations through the licensing agreement with AHC. At the time of the acquisition, through its sales efforts, Green Hygienics was in the process of finalizing several orders for its products with major retailers and distributors in the United States.
	This transaction was treated as a reverse merger therefore the financials prior to the acquisition are those of Green Hygienics which was not in operation and/or in existence therefore the balances reflect zero. There was a related party note which was properly recorded at September 30, 2012 as part of the combined company.
	The purchase price was allocated first to record identifiable acquired assets and assumed liabilities at fair value as follows:
	Cash	$	13,309
	Total assets acquired		13,309
	Liabilities assumed;		(57,437	)
	Net value purchased	$	(44,128	)
	There were no historical operations and no expenses for Green Hygienics as of the purchase date. The stock of the Company had not been traded in a significant period; therefore the value of the purchase is immaterial offset by stock with no determinable value.
	Sensational Brands, Inc.
	On November 19, 2012, Sensational Brands acquired certain assets via an asset purchase agreement (“APA”) with Sensational Brands, Inc., a Texas corporation (“SBI-TX”). SBI-TX is owned by a former employee of Green Hygienics. The APA was to acquire certain assets, primarily the trademark “SENSATIONAL” as registered with the United States Patent and Trademark Office.
	The Company paid SBI-TX 500,000 warrants for common stock of the Company (see Note 8). The Company recorded the value of the transaction at $290,000.
	Clearly Herbal
	On April 4, 2013, Green Hygienics acquired certain assets via an asset purchase agreement (“APA”) with Clearly Herbal International Ltd., a British Virgin Islands corporation (“CHI-BVI”). The purpose of the APA was to acquire certain assets, primarily the trademark “CLEARLY HERBAL” as registered with the United States Patent and Trademark Office. The Company paid the owner of CHI 300,000 shares of restricted common stock of the Company (see Note 8) and recorded the value of the transaction at $360,000.As a condition of the acquisition, the Company guaranteed that the 10-day volume weighted average price on the date six months after closing to be at least $1.20. The Company will be obligated to issue additional shares of restricted common stock should the price be below $1.20. As a condition of the acquisition, the Company guaranteed that the 10-day volume weighted average price on the date six months after closing to be at least $1.20. The Company was obligated to issue additional shares of restricted common stock should the price be below $1.20. On October 4, 2013, the common stock of the Company was $0.18 therefore, on October 7, 2013 an additional 1,700,000 shares of restricted stock were issued (see Note 8).
	On April 4, 2013, Green Hygienics contracted to acquire certain assets via an asset purchase agreement (“APA”) with Clearly Herbal International Ltd., a United Kingdom corporation (“CHI-UK”). The purpose of the APA was to acquire certain assets, primarily the trademark “CLEARLY HERBAL” as registered in the United Kingdom. The closing date was set for July 4, 2013 or earlier but has been extended until August 31, 2013. The Company paid the owner of CHI 200,000 shares of restricted common stock of the Company (see Note 8) and recorded the value of the transaction at $240,000.As a condition of the acquisition, the Company guaranteed that the 10-day volume weighted average price on the date six months after closing to be at least $1.20. The Company was obligated to issue additional shares of restricted common stock should the price be below $1.20. On October 4, 2013, the common stock of the Company was $0.18 therefore, on October 7, 2013 an additional 1,133,333 shares of restricted stock were issued (see Note 8).
	Licensing Agreement
	On May 31, 2013, Green Hygienics entered into a Licensing Agreement with Tauriga Sciences, Inc. (”Tauriga”) to grant Tauriga the North American exclusive rights to commercially market certain products related to hospital grade wipes including paper, green and 100% tree-free bamboo-based and biodegradable. The agreement has a term of five years with a five year extension. Tauriga agreed to pay Green Hygienics $250,000 for the fee which was payable on the following terms; $65,000 upon execution of the agreement and $185,000 within ninety days of receipt of samples of the products and applicable marketing material. Tauriga, a publicly registered entity trading under the symbol “TAUG,” and Green Hygienics agreed to the exchange of restricted common stock of TAUG and Green Innovations equal to a present day value of $250,000. On September 18, 2013, as Tauriga had satisfied the licensing fee, the Company issued to Tauriga 625,000 shares of common stock which were valued at $0.40 per share on the date of the transaction and recorded accordingly. Tauriga issued 4,347,826 shares of its common stock on July 16, 2013. Bruce Harmon, the CFO and Chairman of the Company, is also the former CFO of Tauriga (see Note 6). The transaction was completed as an arm’s length transaction. Tauriga has paid $143,730 in cash and, as a settlement for the remaining $106,270 payable to the Company, the Company received an additional 2,500,000 shares of common stock of Tauriga. As of June 30, 2014, the Company had sold all of the shares and recognized a net gain on the sale of $321,455.
	The Company has recorded the following intangibles related to the acquisitions:
					Accumulated
		Asset			Amortization			Net
	Intangibles - December 31, 2013	$	890,000		$	(51,589	)	$	838,411
	Additions		-			-			-
	Amortization		-			(29,667	)		(29,667	)
	Intangibles - June 30, 2014	$	890,000		$	(81,256	)	$	808,744

3_GOING_CONCERN

3. GOING CONCERN	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 3 - GOING CONCERN	'
	The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained net losses of $3,748,022 and used cash in operating activities of $526,366 for the six months ended June 30, 2014. The Company had working capital deficit, stockholders’ deficiency and accumulated deficit of $2,194,418, $2,275,736 and $13,288,682, respectively, at June 30, 2014. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from third parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts.
	The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

4_CONVERTIBLE_NOTES_PAYABLE_AN

4. CONVERTIBLE NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE RELATED PARTIES, NET OF DISCOUNTS AND PREMIUMS	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 4 - CONVERTIBLE NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE RELATED PARTIES, NET OF DISCOUNTS AND PREMIUMS	'
	Notes and convertible notes payable, all classified as current at June 30, 2014 and December 31, 2013, consists of the following:
		30-Jun-14									31-Dec-14
									Principal,									Principal,
	Convertible notes and line of credit,			Put		Debt			net of				Put		Debt			net of
	net of discounts	Principal		Premium		Discounts			Discounts		Principal		Premium		Discounts			Discounts
	Coventry Capital, LLC  (1)	$	30,000	$	3,333	$	-		$	33,333	$	30,000	$	3,333	$	-		$	33,333
	Coventry Capital, LLC  (1)		50,000		5,556		-			55,556		50,000		5,556		-			55,556
	Coventry Capital, LLC  (1)		20,000		2,222		-			22,222		20,000		2,222		-			22,222
	Coventry Capital, LLC  (1)		35,000		3,889		-			38,889		35,000		3,889		-			38,889
	Coventry Capital, LLC  (1)		50,000		5,556		-			55,556		50,000		5,556		-			55,556
	Avanti Distribution, Inc. (1)		9,560		4,097		-			13,657		9,560		4,097		(3,074	)		10,583
	RJR Manufacturers' Agent, Inc.		50,000		-		-			50,000		50,000		-		-			50,000
	RJR Manufacturers' Agent, Inc.		100,000		-		-			100,000		100,000		-		-			100,000
	RJR Manufacturers' Agent, Inc.		50,000		50,000		-			100,000		50,000		50,000		(30,000	)		70,000
	Black Mountain Equities, Inc.		-		-		-			-		55,000		-		-			55,000
	TCA Global Credit Master Fund, LP		1,182,846		1,500,000		(527,857	)		2,154,989		950,003		1,000,000		(582,822	)		1,367,181
	LG Capital Funding, LLC		-		-		-			-		76,500		62,591		-			139,091
	Black Mountain Equities, Inc.		55,000		-		-			55,000		-		-		-			-
	Avanti Distribution, Inc.		354,000		-		-			354,000		-		-		-			-
	Total	$	1,986,406	$	1,574,653	$	(527,857	)	$	3,033,202	$	1,476,063	$	1,137,244	$	(615,896	)	$	1,997,411
	(1) At 12/31/13, classified as long-term liability.
	On August 15, 2012, the Company executed a convertible promissory note with Coventry Capital, LLC (“Coventry Capital”) for $30,000. The note bears interest at the rate of 10% per annum which accrues. As of June 30, 2014 and December 31, 2013, the accrued interest was $5,785 and $4,285, respectively. The note matures on August 15, 2014. The conversion price is equal to 90% of the average of the closing prices of the Company’s common stock for the preceding five trading days. Due to the lack of trading and no market for the common stock of the Company, any discount value is unable to be calculated at this time.
	On August 29, 2012, Green Hygienics executed a convertible promissory with Kachess Financial Corporation (“Kachess”) for $19,500. The note bears interest at the rate of 12% per annum which accrues. The conversion price is the lower of $0.01 per share or 70% of the average of the closing prices of the Company’s common stock for the preceding three trading days. As part of the acquisition of Green Hygienics by Green Innovation, the notes were assumed by Green Innovations. Due to the lack of trading and no market for the common stock of the Company, any discount value is unable to be calculated at this time. On February 13, 2013, the Company repaid the principal and accrued interest of $1,077 for a total payment of $20,577.
	On August 30, 2012, Green Hygienics executed a convertible promissory with Kachess for $20,000. The note bears interest at the rate of 12% per annum which accrues. The conversion price is the lower of $0.01 per share or 70% of the average of the closing prices of the Company’s common stock for the preceding three trading days. As part of the acquisition of Green Hygienics by Green Innovation, the notes were assumed by Green Innovations. Due to the lack of trading and no market for the common stock of the Company, any discount value is unable to be calculated at this time. On February 13, 2013, the Company repaid the principal and accrued interest of $1,098 for a total payment of $21,098.
	On September 4, 2012, Green Hygienics executed a convertible promissory with Kachess for $6,800. The note bears interest at the rate of 12% per annum which accrues. The conversion price is the lower of $0.01 per share or 70% of the average of the closing prices of the Company’s common stock for the preceding three trading days. As part of the acquisition of Green Hygienics by Green Innovation, the notes were assumed by Green Innovations. Due to the lack of trading and no market for the common stock of the Company, any discount value is unable to be calculated at this time. On February 13, 2013, the Company repaid the principal and accrued interest of $362 for a total payment of $7,162.
	On October 4, 2012, Green Hygienics executed a convertible promissory with Kachess for $3,000. The note bears interest at the rate of 12% per annum which accrues. The conversion price is the lower of $0.01 per share or 70% of the average of the closing prices of the Company’s common stock for the preceding three trading days. As part of the acquisition of Green Hygienics by Green Innovation, the notes were assumed by Green Innovations. Due to the lack of trading and no market for the common stock of the Company, any discount value is unable to be calculated at this time. On February 13, 2013, the Company repaid the principal and accrued interest of $130 for a total payment of $3,130.
	On October 17, 2012, the Company executed a convertible promissory note with Coventry Capital for $50,000. The note bears interest at the rate of 10% per annum which accrues. As of June 30, 2014 and December 31, 2013, the accrued interest was $8,541 and $6,041, respectively. The note matures on October 17, 2014. The conversion price is equal to 90% of the average of the closing prices of the Company’s common stock for the preceding five trading days. Due to the lack of trading and no market for the common stock of the Company, any discount value was not calculated.
	On December 6, 2012, the Company executed a convertible promissory note with Coventry Capital for $20,000. The note bears interest at the rate of 10% per annum which accrues. As of June 30, 2014 and December 31, 2013, the accrued interest was $3,142 and $2,142, respectively. The note matures on December 6, 2014. The conversion price is equal to 90% of the average of the closing prices of the Company’s common stock for the preceding five trading days. Due to the lack of trading and no market for the common stock of the Company, any discount value was not calculated.
	On December 18, 2012, the Company executed a convertible promissory note with Coventry Capital for $35,000. The note bears interest at the rate of 10% per annum which accrues. As of June 30, 2014 and December 31, 2013, the accrued interest was $5,384 and $3,634, respectively. The note matures on December 8, 2014. The conversion price is equal to 90% of the average of the closing prices of the Company’s common stock for the preceding five trading days. Due to the lack of trading and no market for the common stock of the Company, any discount value was not calculated.
	On December 28, 2012, the Company executed a convertible promissory note with Coventry Capital for $50,000. The note bears interest at the rate of 10% per annum which accrues. As of June 30, 2014 and December 31, 2013, the accrued interest was $7,555 and $5,055, respectively. The note matures on December 28, 2014. The conversion price is equal to 90% of the average of the closing prices of the Company’s common stock for the preceding five trading days. Due to the lack of trading and no market for the common stock of the Company, any discount value was not calculated.
	On March 14, 2013, the Company executed a convertible promissory note with Avanti Distribution, Inc. for $9,560. The note bears interest at the rate of 12% per annum which accrues. As of June 30, 2014 and December 31, 2013, the accrued interest was $1,495 and $921, respectively. The note matures on March 14, 2015. The conversion price is equal to 70% of the average of the closing prices of the Company’s common stock for the preceding five trading days. The Company recorded a debt discount of $3,756.
	On April 4, 2013, RJR Manufacturers’ Agent, an independent consultant of the Company, requested that the Company convert its accrued compensation balance of $50,000 into a convertible note payable with 12% interest per annum, with a conversion feature of $0.68 per share, the closing price of the prior day, or a 30% discount at the date of conversion, whichever is lesser. A beneficial conversion feature of $31,513 was recorded and will be accreted monthly from the issuance date of the note through maturity. As of June 30, 2014 and December 31, 2013, the accrued interest was $7,488 and $4,488, respectively. The note matured on October 4, 2013. The maturity date was extended to December 31, 2013. On January 1, 2014, the note was extended to June 30, 2014. On June 30, 2014, the note was extended to September 30, 2014. As a condition of the October 4, 2013 extension, the Company agreed to modify the conversion terms to a discount of 40% of the average of the lowest five days closing price from the date of the note until the conversion date.
	On April 15, 2013, the Company entered into a one year convertible promissory note agreement for up to $500,000 with JMJ Financial (“JMJ”). The note has an interest rate of 5% per annum of the $500,000 earned as of the 91st day of the note. The note, at the holder’s option, is convertible at $1.04 per share and if the price per share at the time of conversion is greater than $1.04 per share, on average for the previous 25 trading days, the conversion rate shall have a 25% discount, with the minimum price of $1.04 per share. On April 17, 2013, the Company received $100,000. A beneficial conversion feature of $33,333 was recorded and will be accreted monthly from the issuance date of the note through maturity. On June 26, 2013, JMJ amended the agreement and funded the Company an additional $50,000. A beneficial conversion feature of $39,216 was recorded and will be accreted monthly from the issuance date of the note through maturity. As of September 30, 2013, the accrued interest was $60,000. On October 17, 2013, JMJ filed a conversion of $24,660 into 300,000 shares of common stock based on the calculated price of $0.0822. The Company, per the provisions of the note, issued an objection to the conversion. On October 30, 2013, the Company settled on a repayment of $150,000 thereby extinguishing the note and all related liabilities in their entirety. JMJ returned to the Company the previously issued shares of stock of the Company.
	On May 8, 2013, the Company entered into a convertible promissory note with Avalon Capital Corp. (“Avalon”) for $100,000. The note bears interest at 12% per annum, matured on November 8, 2013, and converts at the lesser of $0.55 per share or a 40% discount at the time of conversion. A beneficial conversion feature of $100,000 was recorded and will be accreted monthly from the issuance date of the note through maturity. On November 10, 2013, Avalon assigned this note to RJR Manufacturers’ Agent. As of June 30, 2014 and December 31, 2013, the accrued interest was $13,858 and $7,858, respectively. The note matured on November 8, 2013. The note was extended to December 31, 2013. On January 1, 2014, the note was extended to June 30, 2014. On June 30, 2014, the note was extended to September 30, 2014. As a condition of the November 8, 2013 extension, the Company agreed to modify the conversion terms to a discount of 40% of the average of the five lowest closing prices from the date of the note until the conversion date.
	On May 20, 2013, the Company entered into a convertible promissory note agreement for $105,000 with Evolution Capital, LLC (“Evolution”). The note has an interest rate of 12% per annum and is accrued. The note, at the holder’s option, is convertible at the lesser of $0.54 or 40% of the average 10 days prior to conversion. A beneficial conversion feature of $105,000 was recorded and will be accreted monthly from the issuance date of the note through maturity. As of September 30, 2013, the accrued interest was $4,626. The note matured on February 20, 2014. On November 26, 2013, the Company and Evolution entered into a Note Termination Agreement as the Company paid Evolution a settlement of $147,000, of which $4,626 was accrued interest and $37,374 was recorded as a loss on settlement of liability.
	On May 30, 2013, the Company entered into a convertible promissory note with Avalon Capital Corp. (“Avalon”) for $50,000. The note bears interest at 12% per annum, matured on November 30, 2013, and converts at the lesser of $0.55 per share or a 40% discount at the time of conversion. A beneficial conversion feature of $50,000 was recorded and was accreted monthly from the issuance date of the note through June 30, 2013. This note was not to have been issued as it was paid back to Avalon by RJR Manufacturers’ Agent. The note was cancelled on August 31, 2013, retroactive to May 30, 2013 for accounting purposes and the accretion was reversed accordingly.
	On June 7, 2013, the Company entered into a convertible promissory note agreement for $76,500 with LG Capital Funding, LLC (“LG Capital”). The note has an interest rate of 8% per annum and is accrued. The note, at the holder’s option, is convertible at a 45% discount to market on average of the lowest 2 days over the prior 10 trading days. A beneficial conversion feature of $76,500 was recorded and will be accreted monthly from the issuance date of the note through maturity. As of September 30, 2013, the accrued interest was $1,945. The note matures on March 7, 2014. On December 6, 2013, the Company paid LG Capital $119,340 as a settlement to terminate the loan. $3,052 of the payment was accrued interest and $39,788 was recorded as a loss on settlement of liability.
	On June 12, 2013, the Company entered into a convertible promissory note agreement for $55,500 with Black Mountain Equities, Inc. (“Black Mountain”). The note has an interest rate of 10% per annum and is accrued. The note, at the holder’s option, is convertible at the lesser of $0.50 or a 25% discount to market on average of the prior 20 trading days. A beneficial conversion feature of $41,111 was recorded and will be accreted monthly from the issuance date of the note through maturity. As a condition of the agreement, the Company issued 10,000 shares of common stock (see Note 8). As of December 31, 2013, the accrued interest was $5,000. The note matures on January 15, 2014. On December 5, 2013, the Company and Black Mountain entered into a Release and Lock Up Leak Out Agreement whereas Black Mountain would be limited to daily sales no greater than 10% of that day’s cumulative trading volume. On January 8, 2014, Black Mountain converted $10,000 of principal into 263,505 shares based on a discounted conversion price of $0.03795 (see Note 8). On January 24, 2014, Black Mountain converted $50,500 of principal and interest into 1,231,708 shares based on a discounted conversion price of $0.0755 (see Note 8). The discounts were recorded as a loss. On February 20, 2014, the Company received $50,000 cash from Black Mountain under the provision in their note that provided, at Black Mountain’s election, the right to fund an additional $50,000 to the Company. An amendment to the convertible note was executed under the same terms and conditions as the original note. The note was recorded as $55,000 which reflects the $5,000 in origination fees associated with the execution of the amendment.
	On July 5, 2013, the Company entered into a convertible promissory note agreement for $76,500 with LG Capital Funding, LLC (“LG Capital”). The note has an interest rate of 8% per annum and is accrued. The note matures on April 5, 2014. The note, at the holder’s option, is convertible at a 45% discount to market on average of the lowest 2 days over the prior 10 trading days. As of December 31, 2013, the accrued interest was $3,035. On January 6, 2014, the Company terminated the note with a payment of $119,340.
	On October 24, 2013, the Company secured financing from TCA Global Credit Master Fund, LP, a Cayman Islands limited partnership (“TCA”). Effective on October 24, 2013, we entered into a Senior Secured Revolving Credit Facility Agreement (the “Credit Agreement”), pursuant to which TCA agreed to loan up to a maximum of $5 million to us for working capital purposes. A total of $892,830 was funded by TCA in connection with the closing. The amounts borrowed pursuant to the Credit Agreement are evidenced by a Revolving Convertible Promissory Note (the “Revolving Note”), the repayment of which is secured by Security Agreements executed by us and our wholly-owned subsidiary, Green Hygienics, Inc. Pursuant to the Security Agreements, the repayment of the Revolving Note is secured by a security interest in substantially all of our assets in favor of TCA. The initial Revolving Note in the amount of $1,000,000 is due and payable along with interest thereon on April 24, 2014, and bears interest at the minimum rate of 18% per annum, increasing to 24% per annum upon the occurrence of an event of default. The conversion rate is 85% of the lowest VWAP of the Company’s stock for the five days preceding the conversion date. We also agreed to pay TCA a fee of $250,000, payable in the form of 2,316,595 shares of common stock. On January 17, 2014, the Company and TCA entered into Amendment No. 1 of the agreement which provided the Company with an additional $500,000. As a condition of the Amendment No. 1, the note maturity date was extended an addition six months. We also agreed to pay TCA a fee of $112,500, payable in the form of 2,684,964 shares of common stock. Both issuances of common stock have a guaranteed value, and any deficiency would require the issuance of additional shares, whereas TCA has a ceiling of the $250,000 and $112,500, respectively, and upon the selling of securities, once those balances are met, the remaining shares of common stock will be returned to the Company for cancellation. On February 3, 2014, the Company and its subsidiary, Green Hygienics, Inc., filed a Complaint in the Circuit Court of the 17th Judicial Circuit in and for Broward County, Florida, against TCA Global Credit Master Fund, LP (“TCA”), regarding a dispute among the parties about the lock-box provisions of the Credit Agreement. On March 17, 2014, the Company settled with TCA and subsequently dismissed the Complaint without prejudice. As part of the settlement and contingent upon the parties’ full performance under the settlement agreement, the parties agreed (1) that the note’s maturity date would be extended to October 25, 2014; (2) that a total amount of $1,506,134.50 was due to TCA under the Credit Agreement and Revolving Note, as amended, as of March 17, 2014; and (3) that $116,982.72 would be wired to TCA within two business days of settlement, and that upon TCA’s receipt of the wire, $1,389,151.78 in principal would be considered outstanding, and no interest and fees would be considered outstanding. As of June 30, 2014, the principal and accrued interest balances were $3,847 and $5,057, respectively.
	On November 1, 2013, RJR Manufacturers’ Agent, an independent consultant of the Company, requested that the Company convert its accrued compensation balance of $50,000 into a convertible note payable with 12% interest per annum, with a conversion feature of $0.14 per share, the closing price of the prior day, or a 40% discount of the five lowest closing prices from the date of the note until the date of conversion, whichever is lesser. A beneficial conversion feature of $50,000 was recorded and will be accreted monthly from the issuance date of the note through maturity. As of June 30, 2014 and December 31, 2013, the accrued interest was $4,003 and $1,003, respectively. The note matured on June 30, 2014. On June 30, 2014, the note was extended until September 30, 2014.
		30-Jun-14									31-Dec-14
									Principal,									Principal,
	Convertible notes,			Put		Debt			net of				Put		Debt			net of
	net of discounts	Principal		Premium		Discounts			Discounts		Principal		Premium		Discounts			Discounts
	Bruce Harmon	$	50,000	$	-	$	-		$	50,000	$	50,000	$	-	$	-		$	50,000
	Bruce Harmon	$	50,000		50,000		-			100,000	$	50,000		50,000		(30,000	)		70,000
	Lakeport Business Services, Inc.		100,000		100,000		-			200,000		100,000		100,000		-			200,000
	Total	$	200,000	$	150,000	$	-		$	350,000	$	200,000	$	150,000	$	(30,000	)	$	320,000
	On April 4, 2013, Harmon, an officer and director of the Company, requested that the Company convert his accrued compensation balance of $50,000 into a convertible note payable with 12% interest per annum, with a conversion feature of $0.68 per share, the closing price of the prior day, or a 30% discount at the date of conversion, whichever is lesser. A beneficial conversion feature of $31,513 was recorded and will be accreted monthly from the issuance date of the note through maturity. As of June 30, 2014 and December 31, 2013, the accrued interest was $7,488 and $4,488, respectively. The note matured on October 4, 2013. The maturity date was extended until December 31, 2013. On January 1, 2014, the note was extended to June 30, 2014. On June 30, 2014, the note was extended until September 30, 2014. As a condition of the January 1, 2014 extension, the Company agreed to modify the conversion terms to a discount of 40% of the lowest five days prior to the conversion date.
	On July 12, 2013, the Company entered into a convertible promissory note agreement for $100,000 with Bruce Harmon, an officer and director of the Company. The note has an interest rate of 12% per annum and is accrued. The note matured on October 12, 2013. The note, at the holder’s option, is convertible at the lesser of $0.31 per share or at a 30% discount to market on the date prior to conversion. As of June 30, 2014 and December 31, 2013, the accrued interest was $11,721 and $5,721, respectively. The note was extended to December 31, 2013. On January 1, 2014, the note was extended to June 30, 2014. On June 30, 2014, the note was extended to September 30, 2014. As a condition of the January 1, 2014 extension, the Company agreed to modify the conversion terms to a discount of 40% of the lowest five days prior to the conversion date.
	On November 1, 2013, Harmon, an officer and director of the Company, requested that the Company convert his accrued compensation balance of $50,000 into a convertible note payable with 12% interest per annum, with a conversion feature of $0.14 per share, the closing price of the prior day, or a 40% discount of the average of the lowest five closing prices from the date of the note until the date of conversion, whichever is lesser. A beneficial conversion feature of $50,000 was recorded and will be accreted monthly from the issuance date of the note through maturity. As of June 30, 2014 and December 31, 2013, the accrued interest was $4,003 and $1,003, respectively. The note matured on June 30, 2014. On June 30, 2014, the note was extended to September 30, 2014.

5_COMMITMENTS_AND_CONTINGENCIE

5. COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 5 - COMMITMENTS AND CONTINGENCIES	'
	Legal Matters
	From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of August 10, 2014, there were no pending or threatened lawsuits except as noted below.
	Ironridge Global IV, Ltd.
	On July 24, 2013, we entered into a stipulation for settlement of claims with Ironridge Global IV, Ltd. (“Ironridge”), pursuant to which we resolved $2,621,037 of our accounts payable that Ironridge had agreed to purchase from our creditors in exchange for payment in full in cash. Pursuant to an order approving stipulation for settlement of claims that we jointly requested from the Los Angeles, California Superior Court, we agreed to issue to Ironridge shares of our common stock with an aggregate value equal to 105% of the claim amount plus reasonable attorney fees, divided by 80% of the following: the closing price of our stock on July 24, 2013, not to exceed the arithmetic average of the volume weighted average prices of any five trading days during a period equal to that number of consecutive trading days following the date of initial receipt of shares required for the aggregate trading volume, excluding after-hours trades, to exceed $25 million, less $0.01 per share, as reported by the Bloomberg Professional service of Bloomberg LP.
	Under the terms of the agreement, Ironridge is prohibited from receiving any shares of common stock that would cause it to be deemed to beneficially own more than 9.99% of our total outstanding shares at any one time. Ironridge received an initial issuance of 3,600,000 common shares, 3,000,000 on September 25, 2013, 4,200,000 on October 23, 2013, 4,400,000 on December 16, 2013, 4,000,000 on January 31, 2014, 4,500,000 on March 20, 2014, 2,500,000 on May 20, 2014, and may be required to return issued or be entitled to receive additional shares, based on the calculation summarized in the prior paragraph. For example, Ironridge would be entitled to approximately 45,315,225 additional shares based on a $0.06 per share closing price of our common stock on June 30, 2014, and that there are 78,188,203 shares of common stock issued and outstanding as of June 30, 2014, and ignoring the 9.99% limitation.
	Ironridge is prohibited from holding any short position in our common stock, and may not to engage in or effect, directly or indirectly, any short sale until at least 180 days after the end of the calculation period described above.
	In addition, for so long as Ironridge holds any shares, it is prohibited from, among other actions: (1) voting any shares of issuer common stock owned or controlled by them, exercising any dissenter’s rights, executing or soliciting any proxies or seeking to advise or influence any person with respect to any voting securities of the issuer; (2) engaging or participating in any actions or plans that relate to or would result in, among other things, (a) acquiring additional securities of the issuer, alone or together with any other person, which would result in them collectively beneficially owning or controlling, or being deemed to beneficially own or control, more than 9.99% of the total outstanding common stock or other voting securities of the issuer, (b) an extraordinary corporate transaction such as a merger, reorganization or liquidation, (c) a sale or transfer of a material amount of assets, (d) changes in the present board of directors or management of the issuer, (e) material changes in the capitalization or dividend policy of the issuer, (f) any other material change in the issuer’s business or corporate structure, (g) actions which may impede the acquisition of control of the issuer by any person or entity, (h) causing a class of securities of the issuer to be delisted, (i) causing a class of equity securities of the issuer to become eligible for termination of registration; or (3) any actions similar to the foregoing.
	On July 25, 2013, we issued shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions.
	On September 25, 2013, we issued 3,000,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions.
	On October 23, 2013, we issued 4,200,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 7.
	On December 16, 2013, we issued 4,400,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 7.
	On January 31, 2014, we issued 4,000,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 7.
	On March 20, 2014, we issued 4,500,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 7.
	On May 20, 2014, we issued 2,500,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 7.
	Oasis Brands, Inc.
	On October 16, 2013, the Company received a letter from the attorneys for Oasis Brands, Inc. (“Oasis Brands”), a competitor of the Company and the former employer of Philip Rundle, the Company’s chief executive officer, Jeff Thurgood, the Company’s vice president of sales, and Awie Kardiman, the Company’s controller. The letter alleges infringement of Oasis Brands’ intellectual property, specifically, their trademark “Fiora.” The letter further requests a cease and desist on the Company’s trademark, “Flora,” as issued by the United States Patent and Trademark Office. Oasis Brands has threaten a lawsuit if the Company does not comply with their demand. The Company, due to information provided by Mr. Rundle, who served as chief executive officer of Oasis Brands and was the signer for the application for Oasis Brands’ trademark “Fiora,” contends that “Fiora” was named after a river in Italy whereas “Flora” is the Spanish word for “flower.” Oasis Brands contends that “Fiora” means flower which the Company adamantly contests due to the information from Mr. Rundle and there is no documented validation that “Fiora” means flower. The Company, in an effort to avoid confrontation, will rename its product, even though this is being done voluntarily to avoid the cost of litigation which would delay the launch of its products for the Spanish market. Furthermore, the Company alleges that this incident is related to Oasis Brands concern over the influence the former key members of Oasis Brands will have for the Company. On December 27, 2013, Oasis Brands filed a Notice of Voluntary Dismissal Without Prejudice of Complaint.
	TCA Global Credit Master Fund, LP
	On February 3, 2014, the Company and its subsidiary, Green Hygienics, Inc., filed a Complaint in the Circuit Court of the 17th Judicial Circuit in and for Broward County, Florida, against TCA Global Credit Master Fund, LP (“TCA”), regarding a dispute among the parties about the lock-box provisions of the Senior Secured Revolving Credit Facility Agreement, as amended. On March 17, 2014, the Company settled with TCA, and on March 20, 2014, dismissed the Complaint without prejudice.
	Lease Commitment
	The Company had an office lease agreement for approximately 1,000 square feet in Cape Coral, Florida pursuant to a lease that will expire on May 31, 2015. Due to a change in ownership of the building, the Company took an opt out option on February 28, 2014. On March 1, 2014, the Company leased approximately 1,542 square feet in Cape Coral, Florida pursuant to a lease that will expire on February 28, 2019. This facility serves as our corporate headquarters. The Company entered into a one year warehouse agreement starting on November 1, 2013 in Ontario, California with approximately 50,000 square feet. The warehouse lease expires on October 31, 2016. Future minimum lease payments under these leases are as follows:
	2014	$	116,332
	2015		233,009
	2016		201,178
	2017		14,868
	2018		14,868
	2019		3,304
	Total	$	583,559
	Rent expense for the six months ended June 30, 2014 and 2013 was $158,993 and $3,635, respectively.
	Other
	On April 4, 2013, Green Hygienics acquired certain assets via an asset purchase agreement (“APA”) with Clearly Herbal International Ltd., a British Virgin Islands corporation (“CHI”). The APA was to acquire certain assets, primarily the trademark “CLEARLY HERBAL” as registered with the United States Patent and Trademark Office. The Company paid the owner of CHI 300,000 shares of restricted common stock of the Company (see Note 2 and 8). As a condition of the acquisition, the Company guaranteed that the 10-day volume weighted average price on the date six months after closing to be at least $1.20. The Company will be obligated to issue additional shares of restricted common stock should the price be below $1.20. The Company was obligated to issue additional shares of restricted common stock should the price be below $1.20. On October 4, 2013, the common stock of the Company was $0.18 therefore, on October 7, 2013 an additional 1,700,000 shares of restricted stock were issued (see Notes 2 and 8).
	On April 4, 2013, Green Hygienics contracted to acquire certain assets via an asset purchase agreement (“APA”) with Clearly Herbal International Ltd., a British Virgin Islands corporation (“CHI”). The APA was to acquire certain assets, primarily the trademark “CLEARLY HERBAL” as registered with in the United Kingdom. The closing date is set for July 4, 2013 or earlier. The Company will pay the owner of CHI 200,000 shares of restricted common stock of the Company (see Note 2 and 8). As a condition of the acquisition, the Company guaranteed that the 10-day volume weighted average price on the date six months after closing to be at least $1.20. The Company will be obligated to issue additional shares of restricted common stock should the price be below $1.20. The Company was obligated to issue additional shares of restricted common stock should the price be below $1.20. On October 4, 2013, the common stock of the Company was $0.18 therefore, on October 7, 2013 an additional 1,133,333 shares of restricted stock were issued (see Notes 2 and 8).
	On May 16, 2013, the Company engaged Brunson Chandler & Jones, PLLC (“BCJ”) as its legal counsel. The engagement requires a monthly payment of $6,000 beginning June 1, 2013, of which a minimum of $1,000 in cash is payable with the remaining portion payable in cash or common stock.
	On July 26, 2013, the Company engaged RedChip Companies, Inc. (“RedChip”), a public and investor relations firm. As part of the eight month agreement, the Company is obligated for a monthly fee of $8,000. On February 7, 2014, the Company terminated the agreement with RedChip.

6_RELATED_PARTIES

6. RELATED PARTIES	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 6 - RELATED PARTIES	'
	Bruce Harmon (“Harmon”), Chairman of the Company, has payables and accruals due to him of $110,664 and $27,671, as of June 30, 2014 and December 31, 2013, respectively.
	Philip Rundle (“Rundle”), CEO and Director of the Company, has payables due to him of $0 and $11,184, as of June 30, 2014 and December 31, 2013, respectively.
	Sugiarto Kardiman (“Kardiman”), CFO of the Company, has payables due to him of $25,775 and $27,991, as of June 30, 2014 and December 31, 2013, respectively.
	On September 26, 2012, with the acquisition of Green Hygienics by Green Innovations, Harmon was issued 49,500,000 shares of common in exchange for the common stock of Green Hygienics.
	On November 19, 2012, a subsidiary of the Company acquired, via an APA, certain assets from SBI-TX, from W. Ray (“Tray”) Harrison, Jr. (“Harrison”), a former employee of Green Hygienics (see Note 2).
	On February 7, 2013, the Company and Harmon executed a Share Cancellation / Exchange / Return to Treasury Agreement. Harmon returned to the Company 45,000,000 shares of common stock in exchange for 5,000,000 shares of Series A preferred stock. The common shares were cancelled (see Note 8).
	On April 4, 2013, Harmon converted accrued compensation into a convertible note payable for $50,000 (see Note 4).
	On April 15, 2013, the Company issued 300,000 shares of common stock to Rundle (see Note 8) as part of his employment agreement.
	On May 16, 2013, the Company amended the agreement with Harmon to issue shares equal to the contractual obligation to Rundle’s employment agreement. Harmon was issued 300,000 shares at a value of $168,000 or $0.56 per share (see Note 8).
	On May 31, 2013, the Company entered into a Licensing Agreement with Tauriga (see Note 2). Harmon, the Chairman of the Company, is also the former CFO of Tauriga.
	On July 9, 2013, W. Ray Harrison, Jr., a former employee of the Company, exercised his 500,000 warrants for common stock on a cashless basis using the prior day’s closing price of $0.3378 thereby a forfeiture of 14,801 shares with an issuance of 485,199 shares of common stock (see Note 2 and 8).
	On July 12, 2013, W. Ray Harrison, Jr., a former employee of the Company, exercised his 250,000 options for common stock on a cashless basis based on the prior day’s closing price of $0.305 thereby a forfeiture of 8,196 shares with an issuance of 241,804 shares of common stock (see Note 8).
	On July 12, 2013, Harmon loaned the Company $100,000 in the form of a convertible note.
	On August 16, 2013, the Company issued Bruce Harmon, the Company’s CFO, 300,000 shares of common stock as compensation for services (see Note 8).
	On September 5, 2013, the Company issued Jeff Thurgood, the Company’s Vice President of Sales, 250,000 shares of common stock as compensation for services (see Note 8).
	On September 5, 2013, the Company issued Determinaction Business Advisory (“DBA”) 300,000 shares of common stock, as compensation for services. Kardiman, the owner of DBA, was serving as the Company’s Controller until June 16, 2014 when he became the CFO. See Note 8.
	On September 10, 2013, the Company issued Rundle 300,000 shares of common stock as a condition of his employment agreement.
	On September 10, 2013, the Company issued Harmon 300,000 shares of common stock as a condition of his employment agreement. See Note 8.
	On November 1, 2013, the Company issued 1,111,111 options for common stock to Bruce Harmon pursuant to the renewal of his employment agreement. The options were valued at $150,000. See Note 8.
	On November 1, 2013, the Company issued 15,000 shares of common stock to Charles Andrews, a member of the Board of Directors of the Company. The shares were valued at $2,100. See Note 8.
	On November 1, 2013, Harmon converted accrued compensation into a convertible note payable for $50,000 (see Note 4).
	On April 1, 2014, the Company issued 1,111,111 options for common stock to Philip Rundle pursuant to the renewal of his employment agreement. The options were valued at $111,111. See Note 8.
	On April 30, 2014, Harmon exchanged 250,000 shares of Series A Preferred Stock for 250,000 shares of Series B Preferred Stock (see Note 8).

7_AMOUNTS_PAYABLE_IN_COMMON_ST

7. AMOUNTS PAYABLE IN COMMON STOCK AND DERIVATIVE LIABILITY	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 7 - AMOUNTS PAYABLE IN COMMON STOCK AND DERIVATIVE LIABILITY	'
	On July 24, 2013, we entered into a stipulation for settlement of claims with Ironridge, pursuant to which we resolved $2,621,037 of our accounts payable that Ironridge had agreed to purchase from our creditors in exchange for payment in full in cash. Pursuant to an order approving stipulation for settlement of claims that we jointly requested from the Los Angeles, California Superior Court, we agreed to issue to Ironridge shares of our common stock with an aggregate value equal to 105% of the claim amount plus reasonable attorney fees, divided by 80% of the following: the closing price of our stock on July 24, 2013, not to exceed the arithmetic average of the volume weighted average prices of any five trading days during a period equal to that number of consecutive trading days following the date of initial receipt of shares required for the aggregate trading volume, excluding after-hours trades, to exceed $25 million, less $0.01 per share, as reported by the Bloomberg Professional service of Bloomberg LP.
	Under the terms of the agreement, Ironridge is prohibited from receiving any shares of common stock that would cause it to be deemed to beneficially own more than 9.99% of our total outstanding shares at any one time. Ironridge received an initial issuance of 3,600,000 common shares, 3,000,000 on September 25, 2013, 4,200,000 on October 23, 2013, 4,400,000 on December 16, 2013, 4,000,000 on February 4, 2014, 4,500,000 on March 20, 2014, 2,500,000 on May 20, 2014, and may be required to return issued or be entitled to receive additional shares, based on the calculation summarized in the prior paragraph (see Note 5 and 8). For example, Ironridge would be entitled to approximately 45,315,225 additional shares based on a $0.06 per share closing price of our common stock on June 30, 2014, and that there are 78,188,203 shares of common stock issued and outstanding as of June 30, 2014, and ignoring the 9.99% limitation.
	Ironridge is prohibited from holding any short position in our common stock, and may not to engage in or effect, directly or indirectly, any short sale until at least 180 days after the end of the calculation period described above.
	In addition, for so long as Ironridge holds any shares, it is prohibited from, among other actions: (1) voting any shares of issuer common stock owned or controlled by them, exercising any dissenter’s rights, executing or soliciting any proxies or seeking to advise or influence any person with respect to any voting securities of the issuer; (2) engaging or participating in any actions or plans that relate to or would result in, among other things, (a) acquiring additional securities of the issuer, alone or together with any other person, which would result in them collectively beneficially owning or controlling, or being deemed to beneficially own or control, more than 9.99% of the total outstanding common stock or other voting securities of the issuer, (b) an extraordinary corporate transaction such as a merger, reorganization or liquidation, (c) a sale or transfer of a material amount of assets, (d) changes in the present board of directors or management of the issuer, (e) material changes in the capitalization or dividend policy of the issuer, (f) any other material change in the issuer’s business or corporate structure, (g) actions which may impede the acquisition of control of the issuer by any person or entity, (h) causing a class of securities of the issuer to be delisted, (i) causing a class of equity securities of the issuer to become eligible for termination of registration; or (3) any actions similar to the foregoing.
	On or about July 25, 2013, we issued 3,600,000 shares of our common stock to Ironridge (see Note 8). The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions.
	On September 25, 2013, we issued 3,000,000 shares of our common stock to Ironridge (see Note 8). The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions.
	As of September 30, 2013, Ironridge has one additional funding of $506,239 to be made on or about October 30, 2013. As of September 30, 2013, $2,114,798 has been funded and 6,600,000 shares of common stock have been issued. The Company incurred $105,740 in fees associated with this transaction. The Company has recorded $1,135,978 as amounts payable in common stock and $417,027 as a derivative liability. See Notes 4 and 9.
	On October 23, 2013, we issued 4,200,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Notes 5.
	On December 16, 2013, we issued 4,400,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 5.
	On January 31, 2014, we issued 4,000,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 5.
	On March 20, 2014, we issued 4,500,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 5.
	On May 20, 2014, we issued 2,500,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Note 5.

8_STOCKHOLDERS_EQUITY

8. STOCKHOLDERS' EQUITY	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 8 - STOCKHOLDERS' EQUITY	'
	Preferred Stock
	The Company authorized 50,000,000 shares of preferred stock with a par value of $0.0001. On November 7, 2012, the Company’s Board of Directors approved the filing of a Certificate of Designation of the Preferences and Rights of Series A Preferred Stock of Green Innovations Ltd. (“Certificate of Designation”) with the Secretary of State of the State of Nevada authorizing the creation of a new series of preferred stock designated as “Series A Preferred Stock” pursuant to the authority granted to the Board of Directors under the Company’s Amended and Restated Certificate of Incorporation and Section NRS 78.1955 of the Nevada General Corporation Law. The Certificate of Designation was filed with the Nevada Department of State on November 7, 2012. The Certificate of Designation created 5,000,000 shares of Series A Preferred Stock. Each holder of Series A Preferred Stock will be entitled to participate in dividends or distributions payable to holders of the Company’s common stock at a rate of the dividend payable to each share of Common Stock multiplied by the number of shares of Common Stock that each share of such holder’s Series A Preferred Stock is convertible into. Each share of Series A Preferred Stock is convertible, at the option of the holder of the Series A Preferred Stock, into one share of the Company’s common stock. Shares of the Series A Preferred Stock will be issued to certain officers of the Company as the Board determines for consideration of the exchange for shares of common stock of the Company. Each share of Series A Preferred Stock will be entitled to ten (10) votes on all matters submitted to a vote of the stockholders of the Company (“Enhanced Voting Rights”). Upon the liquidation, dissolution or winding up of the Company, the holders of the Series A Preferred Stock will participate in the distribution of the Company’s assets with the holders of the Company’s Common Stock pro rata based on the number of shares of Common Stock held by each (assuming conversion of all shares of Series A Preferred Stock). Due to the Enhanced Voting Rights, following the issuance of shares of Series A Preferred Stock, the holders of the Series A Preferred Stock may be able to exercise voting control over the Company. In such case, the holders of the Series A Preferred Stock may gain the ability to control the outcome of corporate actions requiring stockholder approval, including mergers and other changes of corporate control, going private transactions, and other extraordinary transactions. The concentration of voting control in the Series A Preferred Stock could discourage investments in the Company, or prevent a potential takeover of the Company which may have a negative impact on the value of the Company’s securities. In addition, the liquidation rights granted to the holders of the Series A Preferred Stock will have a dilutive effect on the distributions available to the holders of the Company’s common stock. As of June 30, 2014, there were 5,000,000 shares of Series A Preferred Stock issued or outstanding.
	On February 7, 2013, the Company and Harmon executed a Share Cancellation / Exchange / Return to Treasury Agreement. Harmon returned to the Company 45,000,000 shares of common stock in exchange for 5,000,000 shares of Series A preferred stock (see Note 6). The preferred shares were recorded at a value of $500.
	On April 11, 2014, the Company’s Board of Directors approved the filing of a Certificate of Designation of the Preferences and Rights of Series B Preferred Stock of Green Innovations Ltd. (“Certificate of Designation”) with the Secretary of State of the State of Nevada authorizing the creation of a new series of preferred stock designated as “Series B Preferred Stock” pursuant to the authority granted to the Board of Directors under the Company’s Amended and Restated Certificate of Incorporation and Section NRS 78.1955 of the Nevada General Corporation Law. The Certificate of Designation was filed with the Nevada Department of State on April 14, 2014. The Certificate of Designation designated 250,000 shares of the Company’s preferred stock as Series B Preferred Stock. Each holder of Series B Preferred Stock will be entitled to participate in dividends or distributions payable to holders of the Company’s common stock at a rate of the dividend payable to each share of Common Stock multiplied by the number of shares of Common Stock that each share of such holder’s Series B Preferred Stock is convertible into. Each share of Series B Preferred Stock is convertible, at the option of the holder of the Series B Preferred Stock, into one share of the Company’s common stock. Shares of the Series B Preferred Stock will be issued to certain officers of the Company as the Board determines for consideration of the exchange for shares of Series A Preferred Stock of the Company, as already issued. Each share of Series B Preferred Stock will be entitled to one thousand (1,000) votes on all matters submitted to a vote of the stockholders of the Company (“Enhanced Voting Rights”).
	Upon the liquidation, dissolution or winding up of the Company, the holders of the Series B Preferred Stock will participate in the distribution of the Company’s assets with the holders of the Company’s Common Stock pro rata based on the number of shares of Common Stock held by each (assuming conversion of all shares of Series B Preferred Stock). Due to the Enhanced Voting Rights, following the issuance of shares of Series B Preferred Stock, the holders of the Series B Preferred Stock may be able to exercise voting control over the Company. In such case, the holders of the Series B Preferred Stock may gain the ability to control the outcome of corporate actions requiring stockholder approval, including mergers and other changes of corporate control, going private transactions, and other extraordinary transactions. The concentration of voting control in the Series B Preferred Stock could discourage investments in the Company, or prevent a potential takeover of the Company which may have a negative impact on the value of the Company’s securities. In addition, the liquidation rights granted to the holders of the Series B Preferred Stock will have a dilutive effect on the distributions available to the holders of the Company’s common stock. On April 30, 2014, Harmon returned to the Company 250,000 shares of Series A Preferred Stock in exchange for 250,000 shares of Series B Preferred Stock (see Notes 6 and 10). As of June 30, 2014, there were 250,000 shares issued and outstanding.
	Common Stock
	The Company is authorized to issue 50,000,000 shares of common stock, as amended on August 15, 2012, with a par value of $0.0001. The common stock is voting. On September 24, 2012, the Company amended its authorized shares to 150,000,000.
	On August 15, 2012, the Company had a forward split of its stock with twenty shares for one share as the effect. All instances where common stock is mentioned in these statements reflect the 20:1 split.
	On September 26, 2012, the Company acquired Green Hygienics in exchange for 49,500,000 shares of common stock of the Company. These shares were issued in October 2012.
	In October 2012, the two directors and former officers of the Company, Mordechai David and Shamir Benita, cancelled 79,500,000 shares of common stock issued to them.
	On January 18, 2013, the Company sold 300,000 shares of restricted common stock to Belmont Group Ltd. for $180,000 at a price of $0.60 per share.
	On February 4, 2013, the Company appointed K. Parmar to its Advisory Board. As compensation for the appointment, K. Parmar was issued 12,500 shares quarterly for his service.
	On February 7, 2013, the Company and Harmon executed a Share Cancellation / Exchange / Return to Treasury Agreement. Harmon returned to the Company 45,000,000 shares of common stock in exchange for 5,000,000 shares of Series A preferred stock. The common shares were cancelled (see Note 6).
	On February 11, 2013, the Company appointed Mark DeFilippo (“DeFilippo”) to its Advisory Board. As compensation for the appointment, DeFilippo will be issued 12,500 shares quarterly for his service. These shares were recorded at a value of $0.97 per share (the closing price the previous day) or $12,125. The shares were issued in April 2013 (see Note 6).
	On February 12, 2013, the Company sold 107,143 shares of restricted common stock to Coventry Capital for $150,000 at a price of $1.40 per share (the closing price the previous day).
	On February 18, 2013, the Company appointed Sandy Greenberg (“Greenberg”) to its Advisory Board. As compensation for the appointment, Greenberg will be issued 12,500 shares quarterly for his service. These shares were recorded at a value of $2.22 per share (the closing price the previous day) or $27,750. The shares were issued in April 2013 (see Note 6).
	On February 18, 2013, the Company appointed Michael Perfetti (“Perfetti”) to its Advisory Board. As compensation for the appointment, Perfetti will be issued 12,500 shares quarterly for his service. These shares were recorded at a value of $2.22 per share (the closing price the previous day) or $27,750. The shares were issued in April 2013 (see Note 6).
	On February 19, 2013, the Company appointed Y. Parmar to its Advisory Board. As compensation for the appointment, Y. Parmar will be issued 12,500 shares quarterly for his service. These shares were recorded at a value of $2.22 per share (the closing price the previous day) or $27,750. The shares were issued in April 2013 (see Note 6).
	On February 19, 2013, the Company declared a share dividend on a basis of 1.24:1 as of the record date of February 19, 2013, thereby all common shareholders shall receive 0.24 of a share for every one share owned. The Company’s issued and outstanding shall increase from 25,000,000 to 31,000,000 shares of common stock. The shares issued to Y. Parmar, DeFilippo, Greenberg, Perfetti and K. Parmar were not eligible for the dividend as they were not issued. The shares of common stock purchased by Coventry Capital on February 12, 2013 were not issued prior to the dividend therefore the Company issued and additional 46,611 shares of common stock to Coventry Capital for the dividend (see Note 8). The total shares issued for the dividend was 6,046,611 (see Note 8).
	On February 22, 2013, the Company appointed Rundle to its Advisory Board. As compensation for the appointment, Rundle was to be issued 12,500 shares quarterly for his service. These shares were recorded at a value of $0.51 per share (the closing price the previous day) or $6,375. The shares were issued in April 2013 (see Note 6).
	On February 22, 2013, the Company contracted with Vincent & Rees (“V&R”) to serve as the Company’s legal counsel. As compensation for the agreement, V&R received 250,000 shares of restricted common stock of the Company. These shares were recorded at a value of $0.51 per share (the closing price the previous day) or $127,500. The shares were issued in April 2013.
	On April 4, 2013, in exchange for certain assets of Clearly Herbal International Ltd., a British Virgin Islands corporation (“CHI”), the Company paid the owner of CHI 300,000 shares of restricted common stock for an United States trademark (see Note 2). Additionally, the Company has issuable 200,000 shares of restricted common stock for an United Kingdom trademark (see Note 2). The value of the two transactions was $600,000 or $1.20 per share. As a condition of the acquisition, the Company guaranteed that the 10-day volume weighted average price on the date six months after closing to be at least $1.20. The Company was obligated to issue additional shares of restricted common stock should the price be below $1.20. On October 4, 2013, the common stock of the Company was $0.18 therefore, on October 7, 2013 an additional 1,700,000 shares of restricted stock were issued (see Notes 2 and 5).
	On April 4, 2013, Y. Parmar, a member of the Advisory Board, purchased 100,000 shares of common stock at a discounted price of $0.54 per share for $50,000 (see Note 6).
	On April 4, 2013, Alain Cameron purchased 55,555 shares of common stock at a discounted price of $0.54 per share for $30,000.
	On April 15, 2013, the Company granted 300,000 shares of common stock to Rundle, the chief executive officer of the Company, as part of his employment agreement. The Company recorded the value of the shares at $268,750 or $0.90 per share (see Note 6).
	On May 8, 2013, N. Parmar, a co-owner of American Hygienics Corporation, a supplier to the Company, purchased 125,000 shares of common stock at a discounted price of $0.40 per share for $50,000.
	On May 8, 2013, K. Parmar, a member of the Advisory Board and co-owner of American Hygienics Corporation, a supplier to the Company, purchased 125,000 shares of common stock at a discounted price of $0.40 per share for $50,000 (see Note 6).
	On May 16, 2013, the Company amended the agreements with Harmon and RJR Manufacturers’ Agent (“RJR”) to issue shares equal to the contractual obligation to Rundle’s employment agreement. Harmon was issued 300,000 shares and RJR has 300,000 shares issuable, at a value of $168,000 each or $0.56 per share. See Note 6 in regards to Harmon.
	On June 15, 2013, the Company issued 20,000 shares of common stock to a consultant for services rendered for June. The shares were recorded at a cost of $9,300.
	On June 18, 2013, the Company issued to BCJ, the Company’s corporate counsel, 111,905 shares of common stock as part of its annual engagement with BCJ, 100,000 shares due on June 1, 2013, and 11,905 shares for the partial month of May, for legal services. The shares were issued at the previous day’s closing price of $0.49 or $54,833. The 100,000 shares will be amortized over one year.
	On June 18, 2013, the Company issued 10,000 shares of common stock to Black Mountain Equities, Inc. as a conditional of financing (see Note 4). The shares were recorded as a debt discount of $5,000 as the stock was valued at $0.50 per share.
	On June 18, 2013, the Company issued 62,500 shares or 12,500 each, to its Advisory Board, Perfetti, Y. Parmar, K. Parmar, Sandberg, and DeFilippo. The shares were valued collectively at $28,750.
	On June 18, 2013, the Company issued 20,000 shares of common stock as compensation to a consultant in regards to services rendered.
	On June 30, 2013, the Company recorded 22,635 shares of common stock issuable to BCJ for June legal fees. The shares were valued at $8,375, or $0.37 per share, and due to an averaging method of calculation, a $3,375 loss on issuance was recorded. The shares were issued in July 2013.
	On July 5, 2013, the Company issued 35,000 shares of common stock as compensation to a consultant in regards to services rendered. The shares were recorded at a cost of $9,451.
	On July 12, 2013, as a condition of financing, the Company issued JMJ 24,390 shares of common stock. The stock, based on the prior day’s closing price of $0.31, was valued at $7,561 and was recorded as a cost of financing. On October 30, 2013, as a condition of the settlement with JMJ, these shares were committed to be returned to the Company (see Notes 4 and 8). The shares were returned on January 6, 2014.
	On July 9, 2013, W. Ray Harrison, Jr., a former employee of the Company, exercised his 500,000 warrants for common stock on a cashless basis using the prior day’s closing price of $0.3378 thereby a forfeiture of 14,801 shares with an issuance of 485,199 shares of common stock (see Note 6).
	On July 12, 2013, W. Ray Harrison, Jr., a former employee of the Company, exercised his 250,000 options for common stock on a cashless basis based on the prior day’s closing price of $0.305 thereby a forfeiture of 8,196 shares with an issuance of 241,804 shares of common stock (see Note 6).
	On July 25, 2013, we issued 3,600,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Notes 5 and 7.
	On July 29, 2013, the Company issued 35,000 shares of common stock as compensation to a consultant in regards to services rendered. The shares were recorded at a cost of $9,450.
	On July 29, 2013, as part of an engagement agreement with RedChip Companies, Inc., a public and investor relations firm, the Company issued 300,000 shares of common stock. The shares were recorded at a cost of $81,300.
	On August 16, 2013, the Company issued 12,500 shares of common stock to Hilton Kahn, a member of the Advisory Board, as his quarterly compensation. The shares were valued at $0.278 per share, the previous day’s price based on July 15, 2013, the date of the contractual obligation, or $3,500. See Note 6.
	On August 16, 2013, the Company issued RJR Manufacturers’ Agent 300,000 shares of common stock, as compensation for services. The shares were valued at $0.278 per share, or $83,370.
	On August 16, 2013, the Company issued Bruce Harmon, the Company’s CFO, 300,000 shares of common stock, as compensation for services. The shares were valued at $0.278 per share, or $83,370 (see Note 6).
	On September 5, 2013, the Company issued DBA 300,000 shares of common stock, as compensation for services. The shares were valued at $0.20 per share, or $60,000. The shares have a three year vesting therefore will be amortized accordingly. As of June 30, 2014, $17,500 has been expensed. See Note 6.
	On September 5, 2013, the Company issued Jeff Thurgood, the Company’s Vice President of Sales, 250,000 shares of common stock, as compensation for services. The shares were valued at $0.20 per share, or $50,000. The shares have a three year vesting therefore will be amortized accordingly. As of June 30, 2014, $14,305 has been expensed. See Note 6.
	On September 6, 2013, the Company issued 35,161 shares of common stock to BCJ for August legal fees. The shares were valued at $10,267, or $0.29 per share, and due to an averaging method of calculation, a $10,267 loss on issuance was recorded.
	On September 6, 2013, the Company issued 41,254 shares of common stock to BCJ for September legal fees. The shares were valued at $9,488.42, or $0.23 per share, and due to an averaging method of calculation, a $5,488 loss on issuance was recorded.
	On September 12, 2013, RJR Manufacturers’ Agent exercised these warrants on a cashless basis based on the prior day’s closing price of $0.3378 thereby a forfeiture of 72,992 shares with an issuance of 927,008 shares of common stock.
	On September 13, 2013, the Company sold 26,087 shares of restricted common stock to an individual for $3,000. The shares sold were discounted by 25% due to the restriction and a loss of $1,043 was recorded.
	On September 18, 2013, the Company issued 200,000 shares of common stock to Kalpesh Vyas as payment for the finalization of the transfer of ownership of the United Kingdom Clearly Herbal trademark (see Notes 2 and 5).
	On September 18, 2013, the Company issued Tauriga 625,000 shares of common stock as obligated under the licensing agreement between Tauriga and GHI (see Note 2).
	On September 18, 2013, the Company issued a shareholder 264 shares of common stock as part of the February 2013 dividend. The shareholder was omitted from the original issuance due to the timing of his ownership. The Company believes that the lack of issuance at the time of dividend was correct but, in order to avoid any potential problems, issued the immaterial amount of shares. The issuance was recorded as a loss of $73 based on the prior day’s closing price of $0.275.
	On September 25, 2013, we issued 3,000,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Notes 5 and 7.
	On October 7, 2013, the Company issued 62,500 shares or 12,500 each, to its Advisory Board, Perfetti, Y. Parmar, K. Parmar, Sandberg, and DeFilippo. The shares were valued collectively at $14,375. See Note 6.
	On October 8, 2013, the Company issued 44,307 shares of common stock to BCJ for legal services. The shares were valued at $13,723, or $0.31 per share, and due to an averaging method of calculation, a $4,861 loss on issuance was recorded.
	On October 8, 2013, the Company issued Clearly Herbal International, a British Virgin Island corporation, an additional 1,700,000 shares of common stock in regards to the Clearly Herbal U.S. trademark and to Clearly Herbal International, a UK corporation, an additional 1,333,333 shares of common stock in regards to the Clearly Herbal UK trademark (see Notes 2 and 5).
	On October 15, 2013, the Company issued 12,500 shares to Hilton Kahn, a new member of the Company’s Advisory Board. The shares were valued at $2,250. See Note 6.
	On October 23, 2013, the Company issued 2,316,595 shares to TCA in conjunction with the financing provided by TCA. The shares were valued at $250,000. See Notes 4 and 5.
	On October 23, 2013, we issued 4,200,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Notes 5 and 7.
	On October 31, 2013, the Company issued 40,000 shares of common stock to BCJ for legal services. The shares were valued at $5,600, or $0.14 per share, and due to an averaging method of calculation, a $1,600 loss on issuance was recorded.
	On November 1, 2013, the Company issued 15,000 shares of common stock to Charles Andrews, a member of the Board of Directors of the Company. The shares were valued at $2,100. See Note 6.
	On November 1, 2013, the Company issued 65,488 shares of common stock to BCJ for legal services. The shares were valued at $14,337, or $0.22 per share, and due to an averaging method of calculation, a $5,168 loss on issuance was recorded.
On November 25, 2013, the Company issued 46,611 shares of common stock to Coventry Capital in regards to the February 2013 dividend.
On November 25, 2013, the Company issued 30,000 shares of common stock to Robert Brennan, a consultant to the Company. Mr. Brennan had previously been issued 30,000 warrants for common stock which was cancelled. The shares were valued at $3,900.
On November 25, 2013, the Company issued 30,000 shares of common stock to Jean-Michel Fitamant, a consultant to the Company. The shares were valued at $3,900.
On November 25, 2013, the Company issued 30,000 shares of common stock to Michele Harris, a leased employee to the Company (became employee in January 2014). The shares were valued at $3,900.
On December 1, 2013, the Company issued 176,219 shares of common stock to BCJ for legal services. The shares were valued at $38,293, or $0.22 per share, and due to an averaging method of calculation, a $17,146 loss on issuance was recorded.
On December 16, 2013, we issued 4,400,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Notes 5 and 7.
On January 1, 2014, the Company issued 131,492 shares of common stock to BCJ for legal services. The shares were valued at $10,519, or $0.08 per share, and due to an averaging method of calculation, a $6,519 loss on issuance was recorded.
On January 2, 2014, the Company sold 190,476 shares of restricted common stock to an individual for $10,000. The shares sold were discounted by 25% due to the restriction and a loss of $4,876 was recognized.
On January 3, 2014, the Company issued 51,471 shares of common stock to Octane, Inc. (“Octane”) for services. The shares were valued at $4,118, or $0.08 per share, and due to a discount due to the restriction, a $1,493 loss on issuance was recorded.
On January 6, 2014, the Company cancelled 24,390 shares of common stock that were previously issued to JMJ (see Note 4). As a condition of the payment of the note to JMJ on October 30, 2013, these shares were agreed to be returned and cancelled.
On January 8, 2014, Black Mountain converted $10,000 of principal of the note dated June 12, 2013, into 263,505 shares of common stock, valued at $21,080. A loss on conversion of $11,080 was recorded. See Note 4.
On January 17, 2014, the Company issued 2,684,964 shares of common stock to TCA (see Notes 4 and 5) in conjunction with the financing provided by TCA. The shares were valued at $225,537. The shares have a guaranteed value of $112,500 and TCA cannot exceed that amount. As applicable, upon sale and recognition of the above stated compensation, any remaining shares will be returned to the Company for cancellation. The Company recorded a receivable of $113,037 in records to the over issuance value.
On January 22, 2014, the Company sold 152,000 shares of restricted common stock to an employee for $9,975. The shares sold were discounted by 25% due to the restriction and a loss of $3,705 was recorded.
On January 24, 2014, Black Mountain converted $55,000 of principal and $5,500 of accrued interest of the note dated June 12, 2013, into 1,231,708 shares of common stock, valued at $160,122. A loss on conversion of $99,622 was recorded. See Note 4.
On February 1, 2014, the Company issued 15,000 shares of common stock to Charles Andrews, a director of the Company (see Note 6), for services. The shares were valued at $1,800, or $0.12 per share.
On February 1, 2014, the Company issued 88,418 shares of common stock to BCJ for legal services. The shares were valued at $10,610, or $0.12 per share, and due to an averaging method of calculation, a $6,610 loss on issuance was recorded.
On February 4, 2014, the Company issued 4,000,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Notes 5 and 7.
On March 1, 2014, the Company issued 97,915 shares of common stock to BCJ for legal services. The shares were valued at $11,750, or $0.12 per share, and due to an averaging method of calculation, a $7,750 loss on issuance was recorded.
On March 19, 2014, the Company issued 50,000 shares of common stock to BCJ for additional legal services outside of the agreement between the parties. The shares were valued at $5,000, or $0.10 per share.
On March 19, 2014, 900,000 shares of common stock that were authorized for issuance in 2013 but never issued and recorded as issuable, were issued.
On March 20, 2014, we issued 4,500,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Notes 5 and 7.
On March 25, 2014, the Company issued 150,000 shares of common stock to American Capital Ventures (“ACV”) for investor relation services for three months. The shares were valued at $15,000, or $0.10 per share.
On April 1, 2014, the Company issued 98,804 shares of common stock to BCJ for legal services. The shares were valued at $9,880, or $0.10 per share, and due to an averaging method of calculation, a $5,880 loss on issuance was recorded.
On April 18, 2014, the Company issued 2,500,000 shares of common stock to Mirador Consulting, LLC (“Mirador”) for management consulting for six months. The shares were valued at $225,000, or $0.09 per share. As of June 30, 2014, $93,750 has been expensed and the remaining will be amortized over the remaining period of the contract.
On April 18, 2014, the Company cancelled 87,500 shares of common stock that had been incorrectly issued to the Advisory Board in prior periods.
On April 30, 2014, the Company issued 50,000 shares of common stock to Charles Andrews, a director of the Company (see Note 6), for services. The shares were valued at $4,375, or $0.0875 per share.
On May 1, 2014, the Company issued 109,589 shares of common stock to BCJ for legal services. The shares were valued at $9,863, or $0.09 per share, and due to an averaging method of calculation, a $5,863 loss on issuance was recorded.
On May 20, 2014, we issued 2,500,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions. See Notes 5 and 7.
On June 1, 2014, the Company issued 131,079 shares of common stock to BCJ for legal services. The shares were valued at $10,486, or $0.08 per share, and due to an averaging method of calculation, a $6,486 loss on issuance was recorded.
On June 13, 2014, the Company issued 300,000 shares of common stock to John H. Shaw (“Shaw”) for corporate communications for six months. The shares were valued at $21,000, or $0.07 per share.
Stock Warrants
The Company has granted warrants to employees. As of June 30, 2014 and December 31, 2013, the balance was zero and there was no activity in the period.
On November 19, 2012, the Company issued 500,000 fully vested warrants with an exercise price of $0.01 per share for common stock to W. Ray Harrison, Jr. as compensation for the APA with SBI-TX (see Note 3). The warrants were valued at $0.58 per warrant or $290,000 using the average price for our common stock. On July 9, 2013, Mr. Harrison exercised these warrants on a cashless basis based on the prior day’s closing price of $0.3378 thereby a forfeiture of 14,801 shares with an issuance of 485,199 shares of common stock. See Note 2 and 6.
The Company has granted warrants to non-employees. Warrant activity for non-employees the six months ended June 30, 2014 is as follows:
					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number		Exercise		Contractual		Intrinsic
	of Warrants		Price		Terms		Value
Outstanding at December 31, 2013		2,111,111	$	0.076
Granted		-	$	-
Forfeited		-		-
Exercised		-	$	-
Outstanding at June 30, 2014		2,111,111	$	0.076		4.05	$	52,000
Exercisable at June 30, 2014		2,111,111	$	0.076
Weighted Average Grant Date Fair Value			$	-
On November 1, 2012, the Company issued 1,000,000 fully vested warrants with an exercise price of $0.01 per share for common stock to RJR Manufacturers’ Agent as compensation for services. The warrants were valued at $0.43 per warrant or $430,000 using the average price for our common stock. On September 12, 2013, RJR Manufacturers’ Agent exercised these warrants on a cashless basis based on the prior day’s closing price of $0.3378 thereby a forfeiture of 72,992 shares with an issuance of 927,008 shares of common stock.
On March 17, 2013, the Company issued 1,000,000 fully vested warrants with an exercise price of $0.01 per share for common stock to Ecotrade Solutions Ltd. as compensation for services. The warrants were valued at $0.88 per warrant or $880,000 using the average price for our common stock.
On August 13, 2013, the Company issued 30,000 warrants with an exercise price of $0.28 per share for common stock to Robert Brennan, a consultant to the Company, as compensation for services. On November 25, 2013, the Company cancelled the warrants and issued Mr. Brennan 30,000 shares of common stock.
On November 1, 2013, the Company issued 1,111,111 fully vested warrants with an exercise price of $0.135 per share for common stock to RJR Manufacturers’ Agent as compensation for services. The warrants were valued at $0.135 per warrant or $150,000 using the current price for our common stock.
Stock Options
The Company approved the 2012 Stock Option Plan on November 14, 2012 under which 10,000,000 shares were reserved for issuance.
The Company has granted options to employees. Options activity for the six months ended June 30, 2014 is as follows:
			Weighted		Weighted Average
			Average		Remaining		Aggregate
	Number		Exercise		Contractual		Intrinsic
	of Options		Price		Terms		Value
Outstanding at December 31, 2013	2,111,111		$	0.076
Granted	1,111,111		$	0.1
Exercised	-		$	-
Forfeited		-		-
Expired		-	$	-
Outstanding at June 30, 2014		3,222,222	$	0.084		9.16	$	52,000
Exercisable at June 30, 2014		3,222,222	$	0.082
Weighted Average Grant Date Fair Value			$	0.1
On November 14, 2012, the Company granted Bruce Harmon 1,000,000 options for common stock. The options are fully-vested at issuance, have a five-year life, and have an exercise price of $0.01. The options were valued at $0.53 per option or $530,000 using the average price of our common stock. See Note 6.
On November 14, 2012, the Company granted W. Ray Harrison, Jr. 250,000 options for common stock. The options are fully-vested at issuance, have a five-year life, and have an exercise price of $0.01. The options were valued at $0.53 per option or $132,500 using the average price of our common stock. On July 12, 2013, Mr. Harrison exercised these options on a cashless basis based on the prior day’s closing price of $0.305 thereby a forfeiture of 8,196 shares with an issuance of 241,804 shares of common stock (see Note 6).
On November 1, 2013, the Company granted Bruce Harmon 1,111,111 options for common stock. The options are fully-vested at issuance, have a five-year life, and have an exercise price of $0.135. The options were valued at $0.135 per option or $150,000. See Note 6.
On April 1, 2014, the Company granted Philip Rundle 1,111,111 options for common stock. The options are fully-vested at issuance, have a five-year life, and have an exercise price of $0.10. The options were valued at $0.10 per option or $111,111. See Note 6.

9_CONCENTRATIONS

9. CONCENTRATIONS	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 9 - CONCENTRATIONS	'
	Concentration of Credit Risk
	Financial instruments, which potentially subject the Company to a concentration of credit risk, consist principally of temporary cash investments.
	The Company places its temporary cash investments with financial institutions insured by the FDIC. No amounts exceeded federally insured limits as of June 30, 2014. There have been no losses in these accounts through June 30, 2014.
	Concentration of Intellectual Property
	The Company owns the trademark “SENSATIONAL” and “CLEARLY HERBAL” through the acquisitions from SBI-TX (see Note 2) and CHI (see Note 2), respectively, as filed with the United States Patent and Trademark Office (“USPTO”). Additionally, the Company has filed and been issued the trademark “FLORA” (the Company is not using “FLORA,” see Note 5) and has a patent pending on “SENSATIONALLY.” As of May 20, 2014, the USPTO will have recorded that the Company has abandoned the application for “SENSATIONALLY” and the patent “FLORA.”

10_SUBSEQUENT_EVENTS

10. SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 10 - SUBSEQUENT EVENTS	'
	On July 30, 2014, the Company issued 100,000 shares of common stock to Charles Andrews for his services for the quarter as a director. The shares will be recognized as an expense accordingly.
	On July 30, 2014, the Company entered into a convertible promissory note agreement for $55,000 with Black Mountain. The note has an interest rate of 10% per annum and is accrued. The note, at the holder’s option, is convertible at the lesser of $0.05 or a 25% discount to market on average of the prior 20 trading days. A beneficial conversion feature will be recorded and will be accreted monthly from the issuance date of the note through maturity. The note matures on February 28, 2015.
	On August 12, 2014, we issued 6,400,000 shares of our common stock to Ironridge. The issuance is exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, as the issuance of securities was in exchange for bona fide outstanding claims, where the terms and conditions of such issuance were approved by a court after a hearing upon the fairness of such terms and conditions.

1_NATURE_OF_OPERATIONS_AND_SUM1

1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2014
Nature Of Operations And Summary Of Significant Accounting Policies Policies	'
Organization	'
	Green Innovations Ltd., formerly known as Winecom, Inc. (the “Company,” “we,” “us,” “our,” or “Green Innovations”) is a Nevada corporation. The business was started on July 1, 2008. We changed our name on September 24, 2012.
	Green Hygienics, Inc. (“Green Hygienics”), a Florida corporation, was formed on August 1, 2012. On September 26, 2012, it was acquired by the Company (see Note 2).
	Sensational Brands, Inc. (“Sensational Brands”), a Florida corporation, was formed on November 19, 2012. It was formed for the sole purpose of the acquisition of certain assets of Sensational Brands, Inc., a Texas corporation on November 19, 2012 (see Note 3). Sensational Brands was dissolved in September 2013 and its assets were assumed by Green Hygienics.
Basis of Presentation	'
	The accompanying unaudited consolidated financial statements of Green Innovations Ltd. and Subsidiary have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. The results of operations for the interim period ended June 30, 2014 shown in this report are not necessarily indicative of results to be expected for the full fiscal year ending December 31, 2014. In the opinion of the Company’s management, the information contained herein reflects all adjustments (consisting of normal recurring adjustments and business combination adjustments – see Note 2) necessary for a fair presentation of the Company’s results of operations, financial position and cash flows. The unaudited interim financial statements should be read in conjunction with the audited consolidated financial statements in the Company’s Form 10-K for the year ended December 31, 2013 filed on March 18, 2014 and Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Nature of Operations	'
	The Company was formed to develop an Internet social website that catered to wine lovers. In August 2012, with the acquisition of Green Hygienics, the Company changed its operations to the business of importing and distributing bamboo-based hygienic products. The prior operations of the Company have been abandoned effective with the acquisition of Green Hygienics.
	Green Hygienics is in the importation, sale, and distribution of hygienic and household products made of bamboo-based paper. On August 1, 2012, Green Hygienics entered into a Licensing Agreement with American Hygienics Corporation (“AHC”), a corporation domiciled in the People's Republic of China, pursuant to we acquired the exclusive right for a period of 5 years to import and distribute AHC's proprietary bamboo pulp-based hygiene products. AHC is one of the world's largest manufacturer of bamboo-based wet wipes, is internationally certified (ISO 9001:2008, BRC-CP, EPA, Nordic swan, cGMP and GMP) and a member of the world Private Label Manufacturers Association. Exporting to over 45 countries, AHC supplies a number of Multi-National brands and retailers on all continents including customers such as 3M, Carrefour, Tesco, Walmart, and Goodyear. The Licensing Agreement contemplates the distribution of generic, private label, and Green Hygienics branded products, described below. Subject to certain sales targets being met, the exclusive distribution license will be renewable for an additional period of 5 years.
Principles of Consolidation	'
	The consolidated financial statements include the accounts of Green Innovations and its wholly-owned subsidiary (as of June 30, 2014), Green Hygienics. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates	'
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying consolidated financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets.
Cash and Cash Equivalents	'
	The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
Inventories	'
	Inventories are stated at the lower of cost or market (“LCM”). Inventory consists of finished goods.
Impairment of Long-Lived Assets	'
	The Company accounts for long-lived assets in accordance with the provisions of Statement of Financial Accounting Standards ASC 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.
Fair Value of Financial Instruments	'
	The Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For certain of our financial instruments, including cash, accounts payable, accrued expenses, deposits received from customers for layaway sales and short term loans the carrying amounts approximate fair value due to their short maturities.
	We follow accounting guidance for financial and non-financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
	Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
	Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.
Revenue Recognition	'
	The Company recognizes revenue on our products in accordance with ASC 605-10, “Revenue Recognition in Financial Statements.” Under these guidelines, revenue is recognized on sales transactions when all of the following exist: persuasive evidence of an arrangement did exist, delivery of service has occurred, the sales price to the buyer is fixed or determinable and collectability is reasonably assured. The Company has one primary revenue stream as follows:
		·	Delivery of product to a merchant.
	The Company may have other revenue that deviates from the normal course of business. As of June 30, 2014, the Company has the following other revenue:
		·	Sale of investments – includes the sale of securities obtained for the compensation for the licensing rights to various products of the Company.
Seasonal Revenue	'
	In the retail industry, there are typically seasonal periods of sales which cause fluctuations in revenue. The Company, due to the type of products it sells, does not have seasonal revenues.
Stock-Based Compensation	'
	The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition provisions ASC Topic 505-50. The Company estimates the fair value of stock options at the grant date by using the Black-Scholes option-pricing model.
Net Earnings (Loss) Per Share	'
	In accordance with ASC 260-10, “Earnings Per Share,” basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent shares which may dilute future earnings per share as of June 30, 2014 consist of convertible notes convertible into 44,208,745 common shares. Equivalent shares are not utilized when the effect is anti-dilutive (see Note 8).
Segment Information	'
	In accordance with the provisions of ASC 280-10, “Disclosures about Segments of an Enterprise and Related Information,” the Company is required to report financial and descriptive information about its reportable operating segments. The Company does not have any operating segments as of June 30, 2014 and 2013.
Effect of Recent Accounting Pronouncements	'
	The Company reviews new accounting pronouncements as issued. No new pronouncements had any material effect on these unaudited consolidated financial statements. The accounting pronouncements issued subsequent to the date of these unaudited consolidated financial statements that were considered significant by management were evaluated for the potential effect on these unaudited consolidated financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these unaudited consolidated financial statements as presented and does not anticipate the need for any future restatement of these unaudited consolidated financial statements because of the retro-active application of any accounting pronouncements issued subsequent to June 30, 2014 through the date these unaudited consolidated financial statements were issued.

2_BUSINESS_ACQUISITIONS_ASSET_1

2. BUSINESS ACQUISITIONS, ASSET ACQUISITIONS, AND LICENSING AGREEMENTS (Tables)	6 Months Ended
	Jun. 30, 2014
Business Acquisitions Asset Acquisitions And Licensing Agreements Tables	'
Purchase price allocated first to record identifiable acquired assets and assumed liabilities	'
	The purchase price was allocated first to record identifiable acquired assets and assumed liabilities at fair value as follows:
	Cash	$	13,309
	Total assets acquired		13,309
	Liabilities assumed		(57,437	)
	Net value purchased	$	(44,128	)
Intangibles related to the acquisitions	'
	The Company has recorded the following intangibles related to the acquisitions:
					Accumulated
		Asset			Amortization			Net
	Intangibles - December 31, 2013	$	890,000		$	(51,589	)	$	838,411
	Additions		-			-			-
	Amortization		-			(29,667	)		(29,667	)
	Intangibles - June 30, 2014	$	890,000		$	(81,256	)	$	808,744

4_CONVERTIBLE_NOTES_PAYABLE_AN1

4. CONVERTIBLE NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE RELATED PARTIES, NET OF DISCOUNTS AND PREMIUMS (Tables)	6 Months Ended
	Jun. 30, 2014
Convertible Notes Payable And Convertible Notes Payable Related Parties Net Of Discounts And Premiums Tables	'
Notes and convertible notes payable classified as current	'
	Notes and convertible notes payable, all classified as current at June 30, 2014 and December 31, 2013, consists of the following:
		30-Jun-14									31-Dec-13
									Principal,									Principal,
	Convertible notes and line of credit,			Put		Debt			net of				Put		Debt			net of
	net of discounts	Principal		Premium		Discounts			Discounts		Principal		Premium		Discounts			Discounts
	Coventry Capital, LLC  (1)	$	30,000	$	3,333	$	-		$	33,333	$	30,000	$	3,333	$	-		$	33,333
	Coventry Capital, LLC  (1)		50,000		5,556		-			55,556		50,000		5,556		-			55,556
	Coventry Capital, LLC  (1)		20,000		2,222		-			22,222		20,000		2,222		-			22,222
	Coventry Capital, LLC  (1)		35,000		3,889		-			38,889		35,000		3,889		-			38,889
	Coventry Capital, LLC  (1)		50,000		5,556		-			55,556		50,000		5,556		-			55,556
	Avanti Distribution, Inc. (1)		9,560		4,097		-			13,657		9,560		4,097		(3,074	)		10,583
	RJR Manufacturers' Agent, Inc.		50,000		-		-			50,000		50,000		-		-			50,000
	RJR Manufacturers' Agent, Inc.		100,000		-		-			100,000		100,000		-		-			100,000
	RJR Manufacturers' Agent, Inc.		50,000		50,000		-			100,000		50,000		50,000		(30,000	)		70,000
	Black Mountain Equities, Inc.		-		-		-			-		55,000		-		-			55,000
	TCA Global Credit Master Fund, LP		1,182,846		1,500,000		(527,857	)		2,154,989		950,003		1,000,000		(582,822	)		1,367,181
	LG Capital Funding, LLC		-		-		-			-		76,500		62,591		-			139,091
	Black Mountain Equities, Inc.		55,000		-		-			55,000		-		-		-			-
	Avanti Distribution, Inc.		354,000		-		-			354,000		-		-		-			-
	Total	$	1,986,406	$	1,574,653	$	(527,857	)	$	3,033,202	$	1,476,063	$	1,137,244	$	(615,896	)	$	1,997,411
	(1) At 12/31/13, classified as long-term liability.
Convertible notes payable, net of discount	'
	The note matured on June 30, 2014. On June 30, 2014, the note was extended until September 30, 2014.
		30-Jun-14									31-Dec-13
									Principal,									Principal,
	Convertible notes,			Put		Debt			net of				Put		Debt			net of
	net of discounts	Principal		Premium		Discounts			Discounts		Principal		Premium		Discounts			Discounts
	Bruce Harmon	$	50,000	$	-	$	-		$	50,000	$	50,000	$	-	$	-		$	50,000
	Bruce Harmon	$	50,000		50,000		-			100,000	$	50,000		50,000		(30,000	)		70,000
	Lakeport Business Services, Inc.		100,000		100,000		-			200,000		100,000		100,000		-			200,000
	Total	$	200,000	$	150,000	$	-		$	350,000	$	200,000	$	150,000	$	(30,000	)	$	320,000

5_COMMITMENTS_AND_CONTINGENCIE1

5. COMMITMENTS AND CONTINGENCIES (Tables)	6 Months Ended
	Jun. 30, 2014
Commitments And Contingencies Tables	'
Lease Commitment	'
	Future minimum lease payments under these leases are as follows:
	2014	$	116,332
	2015		233,009
	2016		201,178
	2017		14,868
	2018		14,868
	2019		3,304
	Total	$	583,559

8_STOCKHOLDERS_EQUITY_Tables

8. STOCKHOLDERS' EQUITY (Tables)	6 Months Ended
	Jun. 30, 2014
Granted Warrants to Non Employees [Member]	'
Stock Warrants	'
	The Company has granted warrants to non-employees. Warrant activity for non-employees the six months ended June 30, 2014 is as follows:
						Weighted
				Weighted		Average
				Average		Remaining		Aggregate
		Number		Exercise		Contractual		Intrinsic
		of Warrants		Price		Terms		Value
	Outstanding at December 31, 2013		2,111,111	$	0.076
	Granted		-	$	-
	Forfeited		-		-
	Exercised		-	$	-
	Outstanding at June 30, 2014		2,111,111	$	0.076		4.05	$	52,000
	Exercisable at June 30, 2014		2,111,111	$	0.076
	Weighted Average Grant Date Fair Value			$	-
Granted Options to Employees [Member]	'
Stock Warrants	'
	The Company has granted options to employees. Options activity for the six months ended June 30, 2014 is as follows:
				Weighted		Weighted Average
				Average		Remaining		Aggregate
		Number		Exercise		Contractual		Intrinsic
		of Options		Price		Terms		Value
	Outstanding at December 31, 2013	2,111,111		$	0.076
	Granted	1,111,111		$	0.1
	Exercised	-		$	-
	Forfeited		-		-
	Expired		-	$	-
	Outstanding at June 30, 2014		3,222,222	$	0.084		9.16	$	52,000
	Exercisable at June 30, 2014		3,222,222	$	0.082
	Weighted Average Grant Date Fair Value			$	0.1

1_NATURE_OF_OPERATIONS_AND_SUM2

1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	Jun. 30, 2014
Nature Of Operations And Summary Of Significant Accounting Policies Details Narrative	'
Convertible notes convertible into common shares	44,208,745

2_BUSINESS_ACQUISITIONS_ASSET_2

2. BUSINESS ACQUISITIONS, ASSET ACQUISITIONS, AND LICENSING AGREEMENTS (Details) (USD $)	Jun. 30, 2014
Business Acquisitions Asset Acquisitions And Licensing Agreements Details	'
Cash	$13,309
Total assets acquired	13,309
Liabilities assumed	-57,437
Net value purchased	($44,128)

2_BUSINESS_ACQUISITIONS_ASSET_3

2. BUSINESS ACQUISITIONS, ASSET ACQUISITIONS, AND LICENSING AGREEMENTS (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2013
Assets [Member]	'
Intangibles - December 31, 2013	$890,000
Additions	'
Amortization	'
Intangibles - June 30, 2014	890,000
Accumulated Amortization [Member]	'
Intangibles - December 31, 2013	-51,589
Additions	'
Amortization	-29,667
Intangibles - June 30, 2014	-81,256
Net [Member]	'
Intangibles - December 31, 2013	838,411
Additions	'
Amortization	-29,667
Intangibles - June 30, 2014	$808,744

2_BUSINESS_ACQUISITIONS_ASSET_4

2. BUSINESS ACQUISITIONS, ASSET ACQUISITIONS, AND LICENSING AGREEMENTS (Details Narrative) (USD $)	6 Months Ended
	Jun. 30, 2014
Business Acquisitions Asset Acquisitions And Licensing Agreements Details Narrative	'
Recognized net gain on sale of stock	$321,455

3_GOING_CONCERN_Details_Narrat

3. GOING CONCERN (Details Narrative) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Going Concern Details Narrative	'	'	'	'	'
Net losses	$925,117	$869,464	$3,748,022	$2,066,361	'
Cash used in operating activities	'	'	526,366	1,039,242	'
Working capital deficiency	2,194,418	'	2,194,418	'	'
Stockholders deficiency	2,275,736	'	2,275,736	'	577,067
Accumulated deficit	$13,288,682	'	$13,288,682	'	$9,540,660

4_CONVERTIBLE_NOTES_PAYABLE_AN2

4. CONVERTIBLE NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE RELATED PARTIES, NET OF DISCOUNTS AND PREMIUMS (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Notes and convertible notes, Principal	$1,986,406	$1,476,063
Notes and convertible notes, Put Premium	1,574,653	1,137,244
Notes and convertible notes, Debt discount	-527,857	-615,896
Notes and convertible notes, Principal Net of Discounts	3,033,202	1,997,411
June 30, 2014 [Member]	'	'
Notes and convertible notes, Principal	200,000	200,000
Notes and convertible notes, Put Premium	150,000	150,000
Notes and convertible notes, Debt discount	'	-30,000
Notes and convertible notes, Principal Net of Discounts	350,000	320,000
Coventry Capital, LLC One [Member]	'	'
Notes and convertible notes, Principal	30,000	30,000
Notes and convertible notes, Put Premium	3,333	3,333
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	33,333	33,333
Coventry Capital, LLC Two [Member]	'	'
Notes and convertible notes, Principal	50,000	50,000
Notes and convertible notes, Put Premium	5,556	5,556
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	55,556	55,556
Coventry Capital, LLC Three [Member]	'	'
Notes and convertible notes, Principal	20,000	20,000
Notes and convertible notes, Put Premium	2,222	2,222
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	22,222	22,222
Coventry Capital, LLC Four [Member]	'	'
Notes and convertible notes, Principal	35,000	35,000
Notes and convertible notes, Put Premium	3,889	3,889
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	38,889	38,889
Coventry Capital, LLC Five [Member]	'	'
Notes and convertible notes, Principal	50,000	50,000
Notes and convertible notes, Put Premium	5,556	5,556
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	55,556	55,556
Avanti Distribution, Inc. [Member]	'	'
Notes and convertible notes, Principal	9,560	9,650
Notes and convertible notes, Put Premium	4,097	4,097
Notes and convertible notes, Debt discount	'	-3,074
Notes and convertible notes, Principal Net of Discounts	13,657	10,583
RJR Manufacturers' Agent, Inc. [Member]	'	'
Notes and convertible notes, Principal	50,000	50,000
Notes and convertible notes, Put Premium	'	'
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	50,000	50,000
RJR Manufacturers' Agent, Inc. 2 [Member]	'	'
Notes and convertible notes, Principal	100,000	100,000
Notes and convertible notes, Put Premium	'	'
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	100,000	100,000
RJR Manufacturers' Agent, Inc. 3 [Member]	'	'
Notes and convertible notes, Principal	50,000	50,000
Notes and convertible notes, Put Premium	50,000	50,000
Notes and convertible notes, Debt discount	'	-30,000
Notes and convertible notes, Principal Net of Discounts	100,000	70,000
Black Mountain Equities, Inc. [Member]	'	'
Notes and convertible notes, Principal	'	55,000
Notes and convertible notes, Put Premium	'	'
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	'	55,000
TCA Global Credit Master Fund, LP [Member]	'	'
Notes and convertible notes, Principal	1,182,846	950,003
Notes and convertible notes, Put Premium	1,500,000	1,000,000
Notes and convertible notes, Debt discount	-527,857	-582,822
Notes and convertible notes, Principal Net of Discounts	2,154,989	1,367,181
LG Capital Funding, LLC [Member]	'	'
Notes and convertible notes, Principal	'	76,500
Notes and convertible notes, Put Premium	'	62,591
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	'	139,091
Black Mountain Equities, Inc. One [Member]	'	'
Notes and convertible notes, Principal	55,000	'
Notes and convertible notes, Put Premium	'	'
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	55,000	'
Avanti Distribution, Inc. One [Member]	'	'
Notes and convertible notes, Principal	354,000	'
Notes and convertible notes, Put Premium	'	'
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	354,000	'
Bruce Harmon [Member] | June 30, 2014 [Member]	'	'
Notes and convertible notes, Principal	50,000	50,000
Notes and convertible notes, Put Premium	'	'
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	50,000	50,000
Bruce Harmon 1 [Member] | June 30, 2014 [Member]	'	'
Notes and convertible notes, Principal	50,000	50,000
Notes and convertible notes, Put Premium	50,000	50,000
Notes and convertible notes, Debt discount	'	-30,000
Notes and convertible notes, Principal Net of Discounts	100,000	70,000
Lakeport Business Services, Inc. [Member] | June 30, 2014 [Member]	'	'
Notes and convertible notes, Principal	100,000	100,000
Notes and convertible notes, Put Premium	100,000	100,000
Notes and convertible notes, Debt discount	'	'
Notes and convertible notes, Principal Net of Discounts	$200,000	$200,000

4_CONVERTIBLE_NOTES_PAYABLE_AN3

4. CONVERTIBLE NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE RELATED PARTIES, NET OF DISCOUNTS AND PREMIUMS (Details Narrative) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Convertible promissory note with Coventry Capital, LLC [Member]	'	'
Accured Interest	$5,785	$4,285
Convertible promissory note with Coventry Capital [Member]	'	'
Accured Interest	8,541	6,041
Convertible promissory note with Coventry Capital One [Member]	'	'
Accured Interest	3,142	2,142
Convertible promissory note with Coventry Capital Two [Member]	'	'
Accured Interest	5,384	3,634
Convertible promissory note with Coventry Capital Three [Member]	'	'
Accured Interest	7,555	5,055
Convertible promissory note with Avanti Distribution [Member]	'	'
Accured Interest	1,495	921
RJR Manufacturers' Agent, Inc. [Member]	'	'
Accured Interest	7,488	4,488
Avalon Capital Corp. [Member]	'	'
Accured Interest	13,858	7,858
LG Capital Funding, LLC [Member]	'	'
Accured Interest	'	3,035
TCA Global Credit Master Fund, LP [Member]	'	'
Accured Interest	3,847	5,057
RJR Manufacturers' Agent, Inc. 2 [Member]	'	'
Accured Interest	4,003	1,003
Bruce Harmon [Member]	'	'
Accured Interest	7,488	4,488
Bruce Harmon 1 [Member]	'	'
Accured Interest	11,721	5,721
Bruce Harmon 2 [Member]	'	'
Accured Interest	$4,003	$1,003

5_COMMITMENTS_AND_CONTINGENCIE2

5. COMMITMENTS AND CONTINGENCIES (Details) (USD $)	Jun. 30, 2014
Commitments And Contingencies Details	'
2014	$116,332
2015	233,009
2016	201,178
2017	14,868
2018	14,868
2019	3,304
Total	$583,559

5_COMMITMENTS_AND_CONTINGENCIE3

5. COMMITMENTS AND CONTINGENCIES (Details Narrative) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Commitments And Contingencies Details Narrative	'	'
Rent expense	$158,993	$3,635

6_RELATED_PARTIES_Details_Narr

6. RELATED PARTIES (Details Narrrative) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Bruce Harmon [Member]	'	'
Due to CEO, CFO, and Chairman of the Company	$110,664	$27,671
Philip Rundle [Member]	'	'
Due to CEO, CFO, and Chairman of the Company	0	11,184
Sugiarto Kardiman [Member]	'	'
Due to CEO, CFO, and Chairman of the Company	$25,775	$27,991

7_AMOUNTS_PAYABLE_IN_COMMON_ST1

7. AMOUNTS PAYABLE IN COMMON STOCK AND DERIVATIVE LIABILITY (Details Narrative) (USD $)	6 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
Common stock issued and outstanding	78,188,203
Additional shares	45,315,225
Closing price	$0.06
Fees and commision	$105,740

8_STOCKHOLDERS_EQUITY_Details

8. STOCKHOLDERS' EQUITY (Details) (USD $)	6 Months Ended
	Jun. 30, 2014
Granted Warrants to Non Employees [Member]	'
Number of Warrants	'
Outstanding at December 31, 2013	2,111,111
Granted	'
Exercised	'
Forfeited	'
Outstanding at June 30, 2014	2,111,111
Exercisable at June 30, 2014	2,111,111
Weighted Average Exercise Price	'
Outstanding at December 31, 2013	$0.08
Outstanding at June 30, 2014	$0.08
Exercisable at June 30, 2014	$0.08
Weighted Average Grant Date Fair Value	'
Weighted Average Remaining Contractual Term	'
Weighted Average Remaining Contractual Term	'4 years 18 days
Aggregate Intrensic Value	'
Outstanding at June 30, 2014	$52,000
Granted Options to Employees [Member]	'
Number of Warrants	'
Outstanding at December 31, 2013	2,111,111
Granted	1,111,111
Exercised	'
Forfeited	'
Expired	'
Outstanding at June 30, 2014	3,222,222
Exercisable at June 30, 2014	3,222,222
Weighted Average Exercise Price	'
Outstanding at December 31, 2013	$0.08
Granted	$0.10
Exercised	'
Forfeited	'
Expired	'
Outstanding at June 30, 2014	$0.08
Exercisable at June 30, 2014	$0.08
Weighted Average Grant Date Fair Value	$0.10
Weighted Average Remaining Contractual Term	'
Weighted Average Remaining Contractual Term	'9 years 1 month 28 days
Aggregate Intrensic Value	'
Outstanding at June 30, 2014	$52,000

8_STOCKHOLDERS_EQUITY_Details_

8. STOCKHOLDERS' EQUITY (Details Narrative) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Series A Preferred Stock issued, shares	5,000,000	'
Series A Preferred Stock outstanding, shares	5,000,000	'
Preferred shares, Value	500	'
Common stock issued	123,503,428	45,315,225
BCJ [Member]	'	'
Common stock issued	22,635	'
Common stock value	8,375	'
Shares par value	0.37	'
Loss on issuance	3,375	'
Mirador Consulting, LLC [Member]	'	'
Expense	93,750	'
Preferred Stock	'	'
Series A Preferred Stock issued, shares	250,000	'
Series A Preferred Stock outstanding, shares	250,000	'